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Abstract 
 
 Periodontitis affects 64.7 million American adults each year. If left untreated, 
periodontitis leads to gum recession, tooth decay and eventual tooth loss. The current treatment 
to regenerate gingival tissue is to use a graft. Graft materials either require surgical harvesting or 
tear easily. The goal of this project was to evaluate Gore
®
 BIO-A
®
 Tissue Reinforcement as a 
scaffold material to mimic the cellular and mechanical properties of gum tissue. The results 
qualitatively showed an increase in cell number and collagen deposition on the scaffold over 14 
days although the collagen deposition was minimal. The scaffold material was mechanically 
stronger than the current benchmark non-autologous graft used in gingival repair, AlloDerm
®
. 
We concluded that Gore
®
 BIO-A
®
 Tissue Reinforcement has the potential to be a material used 
in gingival tissue repair but it presents many limitations that would have to be addressed and 
further testing would be required. 
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Chapter 1: Introduction 
Periodontal disease, or gum disease can be described as a chronic condition evolving 
from gingivitis. Periodontitis affects the gums and bone tissue around the teeth. If left untreated, 
the severity of the disease increases, which leads to tooth mobility, receding gums, inflamed 
gums, bleeding while flossing or brushing, and eventually it may lead to tooth loss (NIDCR, 
2012). The primary cause of infection is bacteria present in the dental plaque. Periodontitis 
affects 47.2%, or 64.7 million, of American adults ages thirty and older in varying degrees 
ranging from mild to severe (Eke et al., 2012).  
Currently there are various methods used to treat periodontitis. The most widely used is 
palatal surgery, the gold standard; although there is continual research being done to develop a 
tissue engineered graft for the regeneration of gingival tissue (Leve, 2001). The palatal graft, also 
known as the subepithelial connective tissue graft, is widely used in reforming gums that have 
been damaged due to periodontal disease (Leve, 2001).  
The palatal grafting procedure was first introduced by Langer and Langer in 1985 and has 
been modified throughout the years (Harpreet, 2011). The subepithelial connective tissue graft is 
used to attain root coverage when treating receded gums caused by the disease (Leve, 2001). One 
of the advantages of using this type of graft is that the regenerated tissue closely matches the 
color of the tissue that was lost (Shanmugam et al., 2012). A disadvantage of this procedure is 
the discomfort to the patients because of the additional donor site that has to be prepared. This 
second wound site also increases the amount of pain as well as the risk of infection (Shanmugam 
et al., 2012). 
There are also other methods of treating periodontitis. Currently, the only alternative to 
autologous treatment is AlloDerm
®
 (A. Lee, personal communication, October 2, 2012). 
AlloDerm
®
 is an acellular dermal matrix obtained from human cadavers manufactured by 
LifeCell. Although promising, AlloDerm
®
 presents its own limitations. AlloDerm
®
 is a much 
more difficult material to handle due to its low mechanical stability and has been found to tear 
easily when being placed into the recipient site (Saadoun, 2008). 
In order to address the drawbacks presented by current treatments, the project team 
created a client statement outlining the need for an alternative graft material that mimics the 
cellular and mechanical properties of gum tissue. The team conducted a literature review to 
determine methods and materials that could potentially be used for this purpose. This research 
led to the development of a possible prototype for a synthetic gum graft using an already 
approved FDA product, Gore
®
 BIO-A
®
. Gore
®
 BIO-A
®
 was designed for soft tissue 
reinforcement and is used in applications such as hernia repair (W.L. Gore & Associates, 2012). 
The team believes this product would be suitable because it is biodegradable so it will be 
completely replaced over time by a patient’s own gingival tissue. Vascularization is an important 
aspect of the tissue surrounding the teeth because without adequate blood supply, the tissue will 
become necrotic. Therefore, the goal of this project was to evaluate GORE
®
 BIO-A
®
 Tissue 
Reinforcement as a scaffold material to mimic the cellular and mechanical properties of gum 
tissue. 
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 Experiments were performed using human gingival connective tissue fibroblasts (hGCF) 
derived from human gingival tissue. Human gingival connective tissue fibroblasts were cultured 
in Dulbecco’s Modified Eagle’s Medium (DMEM) and Ham’s F12 (F12) supplemented with 10% 
Fetal Bovine Serum, 50 units of both Penicillin and Streptomycin, and 4mM I glutamine. Twenty-
four pieces of GORE
®
 BIO-A
®
 were cut to the following dimensions: 2mm x 2mm x 1.7mm. 
hGCFs were indirectly seeded onto nine scaffolds at a density of 375,000 cells/mL. Indirect 
seeding is defined here as adding the appropriate cell suspension first and subsequently adding the 
scaffold to the culture dish. Indirect seeding was used to test if the cells would migrate into the 
scaffold. Alternatively, hGCFs were directly seeded onto nine scaffolds at the same density. 
Direct seeding is defined here as first putting the scaffolds into the wells and then adding the cell 
suspension directly onto the scaffolds. These two different seeding techniques were utilized in 
order to determine which technique would allow for better cell infiltration and cell adherence to 
the scaffold. Both seeding methods were evaluated at three different time points (days 3, 7, and 
14). Both the indirect and direct seeding techniques were compared to a control scaffold, which 
was treated the same as the experimental scaffolds; however it was not seeded with cells. A 
control scaffold was harvested at each time point, to allow for comparison with the seeded 
scaffolds.  
 In order for the scaffold to be used as a gingival graft, the cells must show that they have 
infiltrated and adhered to the scaffold uniformly. A Harris hematoxylin and eosin stain was used 
to visualize the infiltration of the cells into the scaffold at each time point. Overall, the team 
observed that the number of cells that infiltrated the scaffold increased with each time point. 
Additionally, the direct seeding technique allowed for increased cell infiltration than the indirect 
seeding technique. To test how well the cells adhered to the scaffold, a Hoechst stain, which stains 
cell nuclei blue, was performed, in which the scaffold was stained and imaged at each time point. 
This was used to show that the cells adhered to the fibers of the scaffold for both the directly and 
indirectly seeded scaffolds.   
The presence of collagen needed to be verified because it is a major component of 
gingival tissue (Marieb, 2013). A picrosirius red/fast green stain visualized the collagen 
deposited on the scaffold. The direct seeding technique showed more collagen deposition over 14 
days than the indirect technique, however overall there was minimal collagen deposition.  
 In order to test the graft’s mechanical stability, the team conducted uniaxial tensile testing 
and suture pullout testing. The purpose of these experiments was to determine if GORE
®
BIO-A
®
 
had as good as or better mechanical properties than AlloDerm
®
 and to determine whether or not 
hydrating an unseeded piece of GORE
®
BIO-A
®
 in PBS or complete medium would have an 
effect on the mechanical strength of the scaffold. Currently, periodontists prepare the grafts they 
use for periodontal treatment by hydrating them in a saline solution, however since the design 
calls for living cells; the team had to test the effects that complete medium would have on the 
scaffold, which is the substance that the graft would need to be stored in to keep the cells viable. 
A statistical analysis suggested that there was no significant difference between scaffolds soaked 
in PBS versus complete medium. Unfortunately, due to the high volume of cells that would be 
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needed for this test, the team was unable to determine the mechanical properties that the scaffold 
may take on as it is degraded by the cells.  
 The team compared the average elongation to failure and the average stiffness of 
GORE
®
BIO-A
®
 with the same values of AlloDerm
®
,
 
obtained through the literature. In 
comparing the elongation to failure, GORE
®
BIO-A
®
 could be stretched much further, about 
7mm more, before failure than  AlloDerm
®
. Additionally, GORE
®
BIO-A
®
 had a significantly 
higher stiffness and therefore can elastically deform under a larger force than AlloDerm
®
. 
 
  
 In the following report, the team outlines the current treatments used to treat periodontal 
disease and their limitations. The project team presents the design criteria, detailed descriptions 
of alternative designs and the testing procedures conducted on the final design. A more detailed 
discussion of testing and results with respect to the final design validation is presented.  
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Chapter 2: Literature Review 
2.1 Anatomy of the Mouth 
 In order to fully understand the scope of periodontal disease, it is necessary to understand 
the anatomy of the mouth. The entire mouth, with the exception of the teeth, is covered in a 
mucous membrane known as the oral mucosa, which works to protect the body from the entry of 
harmful bacteria as well as to protect the inside of the mouth from injury while chewing (Squier 
and Brogden, 2011). It is made up of “thick stratified squamous epithelium”, which aids in 
withstanding friction; however if abrasion does occur, it also produces antimicrobial peptides to 
prevent infection (Marieb, 2013). The roof of the mouth is divided into two sections: the hard 
palate and soft palate. The hard palate is the rigid surface directly behind the front teeth while the 
soft palate is the smooth surface located towards the back of the mouth (Marieb, 2013). During 
the chewing process, the tongue forces food to the palate to aid in breaking down the food 
(Marieb, 2013). The gingiva, also known as the gums, is the site where periodontal disease takes 
place. The gums are comprised of soft fibrous tissue and split into two sections: the unattached 
gingiva and the attached gingiva. The attached gingiva is adhered to the bone (American Dental 
Association, 2007). The unattached gingiva forms the edges of the gums around and in between 
teeth, surrounding the teeth so as to prevent any bacteria from invading (American Dental 
Association, 2007). A basic structure of the mouth can be seen in Figure 1. 
 
 
Figure 1: Anatomy of the Mouth (Winter 1950) 
http://commons.wikimedia.org/wiki/File:Mouth_illustration-Otis_Archives.jpg  
 
In order to understand how diseases like periodontitis occur, it is also crucial to 
understand the structure of the teeth, seen in Figure 2. Each tooth has two major regions: the 
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crown and the root. The crown is the region that resides above the gums. This part of the tooth is 
directly involved in the chewing process (Columbia University College of Dental Medicine, 
2010). Conversely, the root of the tooth is the part that attaches into the jawbone, covered by the 
gums. This part of the tooth helps attach the tooth into the jaw. The neck is a short region 
connecting the two major parts of the tooth together (Marieb, 2013). 
 
 
Figure 2: Anatomy of a Tooth (Uwemuell 2007)  
http://commons.wikimedia.org/wiki/File:Schematic_section_tooth.svg 
 
Apart from the physical components, the mouth is made up of chemical components as 
well. Saliva, which is mostly made up of water (about 97 percent water), plays a major role in 
the mouth (Marieb, 2013). The pH of the mouth can vary depending on a variety of factors 
including different types of food ingested, but is usually slightly acidic in the 6.75-7 range 
(Marieb, 2013). Some of the components of saliva include: electrolytes, like sodium and 
potassium, salivary amylase, proteins, lysozyme, peroxidases, immunoglobulins, to protect 
against microorganisms, and metabolic wastes (Huang, 2004). Benign bacteria are also present at 
the back of the tongue, which help convert nitrates in the saliva and act to kill harmful bacteria 
(Marieb, 2013). 
 
2.2 Periodontal Disease 
Periodontal disease, as seen in Figure 3, is also referred to as gum disease. It is a chronic 
infection that leads to gingival recession and tooth decay. In severe cases, periodontal disease 
leads to severe bleeding, tooth mobility and tooth loss. The primary cause of infection is bacteria 
present in the dental plaque, however there are also other factors that play a role in the onset and 
progression of the disease (Szkaradkiewicz and Karpiński, 2013).   
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Figure 3: Teeth displaying periodontal disease (Zeron 2010) 
http://commons.wikimedia.org/wiki/File:Periodontitis_Cr%C3%B3nica_Severa.JPG 
2.2.1 Prevalence of Periodontal Disease 
Periodontitis affects 47.2 percent, or 64.7 million, of American adults ages thirty and 
older in varying degrees ranging from mild to severe (Eke et al., 2012). 8.7 percent of American 
adults are affected by mild periodontitis not including gingivitis, 30 percent are affected by 
moderate periodontitis, and 8.5 percent are affected by severe periodontitis (Eke et al., 2012). 
These percentages drastically increase with age. About 24 percent of American adults ages thirty 
to thirty-four are affected by periodontitis while that percentage increases to 70 percent in adults 
ages sixty-five or older (Eke et al., 2012). 
A study by Eke et al., aimed to evaluate the burden of periodontitis on the United States 
population, looked at a variety of demographics to see if there were any trends relating personal 
history to periodontal disease (Eke et al., 2012). It was found that a greater percentage of men 
(56.4 %) were afflicted with periodontitis as compared to women (38.4%) (Eke et al., 2012). 
Prevalence amongst different races was evaluated and found that Mexican-Americans as 
opposed to other races had the highest rate of infection at 66.7% (Eke et al., 2012). Whether or 
not smoking played a role in the occurrence of periodontal disease was also investigated. It was 
found that 64.2% of current smokers were found to have periodontitis (Eke et al., 2012). Social 
status and education were also factors evaluated. 65.4% of people living below the federal 
poverty level and 66.9% of people with less than a high school education were found to be 
affected by periodontal disease (Eke et al., 2012). 
In 2009 the periodontal disease market was valued at about $1.2 billion (Gunnam, 2010). 
Since then, it is estimated that the market will grow at a compound annual growth rate of 6.4 
percent by 2016, which would leave the market valued at about $1.9 billion, which makes sense 
considering increasing prevalence (Gunnam, 2010).  
 
2.2.2 Progression of Periodontal Disease 
The growing market for periodontal disease indicates that it is becoming increasingly 
prevalent as a public health problem, especially in the United States. It has even found its way 
onto national health objectives (U.S. Department of Public Health and Human Services, 2012).  
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In order to combat periodontitis, one must first understand how the disease develops. 
Periodontitis is in fact a severe infection, the main cause being bacteria, particularly Gram 
negative anaerobic bacteria such as Porphyromonas gingivalis (Tenenbaum, 2005). The bacteria, 
mucus, and other particles found in the mouth form a sticky, colorless substance on the teeth 
called plaque. If the plaque is not removed through appropriate brushing and flossing it hardens 
and forms tartar which can only be removed by a professional cleaning. Over time the plaque 
and tartar become increasingly harmful. The bacteria release toxins which lead to the 
inflammation of the gums (Healthwise Staff, 2011). This inflammation correlates to the onset of 
gingivitis, a periodontal disease in which gums become red, swollen, tender, and bleed easily. 
Gingivitis does not involve bone or tissue loss and is reversible with daily oral care (Torpy, 
2008). 
Periodontitis arises from the lack of treatment of gingivitis and is characterized by the 
formation of pockets. The pockets form as inflammation around the teeth cause the gums to pull 
away and form spaces in which the bacteria can aggregate (Darveau, Tanner, and Page, 1997). 
The increased concentration of bacterial toxins stimulate a chronic inflammatory response by the 
immune system which then starts to deteriorate the bone and connective tissue that hold the teeth 
in place. As the disease progresses the teeth become loose and are eventually lost (NIDCR, 
2012).  
Periodontitis comes in various forms depending on the severity of the disease and the 
patient’s current health. Aggressive periodontitis is characterized by rapid tissue and bone loss, 
and it occurs in patients who are clinically healthy in all other respects. Slower, progressive 
detachment and bone loss, along with inflammation within the supporting tissues of the teeth, is 
representative of chronic periodontitis. This particular type is more widely seen in adults 
(Highfield, 2009). Necrotizing periodontitis is one of the most debilitating forms of the disease. 
It is characterized by a widespread infection that leads to the necrosis of gingival tissue, 
periodontal ligament, and alveolar bone, accompanied by lesions in the affected area (Highfield, 
2009). Patients with systemic ailments such as infection by the human immunodeficiency virus 
(HIV), malnutrition, and immunosuppression are most often afflicted by necrotizing periodontitis 
(American Academy of Periodontology, 2012).  
2.2.3 Symptoms and Risk Factors of Periodontal Disease 
As with the prevention of any disease, it is important to note the appearance of symptoms 
as they may be a sign of a serious health problem. With gum disease, it is essential to watch for 
warning signs since symptoms may not visibly occur until the disease is severe. The American 
Academy of Periodontology states that,  “Warning signs include red, swollen, or tender gums, 
bleeding while brushing, flossing, or eating hard food, receding gums, loose or separating teeth, 
pus between the gums and teeth, sores in the mouth, persistent bad breath, and a change in the 
way teeth or partial dentures fit together” (American Academy of Periodontology, 2012).   
Monitoring for the appearance of symptoms is most important for people with factors or 
habits that increase the risk of periodontitis. Many studies have shown that one of the main risk 
factors of this infection is tobacco smoking (Hajikazemi and Osquie, 2012). One such study, 
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conducted by Albander et al., used a structured interview to determine the smoking status of 705 
volunteer participants. The participants then underwent a clinical assessment of their periodontal 
status: 
 
“Cigarette and cigar/pipe smokers had a higher prevalence of moderate and severe 
periodontitis and higher prevalence and extent of attachment loss and gingival 
recession than non-smokers…Smoking cessation efforts should be considered as a 
means of improving periodontal health and reducing tooth loss…” (Albandar et 
al., 200, pp.1874).  
 
The National Institute of Dental and Craniofacial Research (NIDCR) also states that 
smoking is in fact one of the most important risk factors not only associated with the onset of 
periodontal disease but also with a lower possibility for successful treatment (NIDCR, 2012).  
Variance in the disease among the population is due in part to macroscopic differences 
between individuals. Periodontitis is an infection of the gingival tissue that is coupled with an 
inflammatory response. The chronic systemic hyper-inflammatory state of patients affected by 
obesity has been suggested as a risk factor of periodontitis (Karels and Cooper, 2007). Many 
studies have indicated a correlation between body mass index (BMI), an indicator of fat in the 
body based on an individual’s weight and height, and the risk of developing a periodontal 
infection (Håheim, 2011). 
Periodontitis is also more likely to occur when there are great fluctuations in hormonal 
levels. Puberty, pregnancy, and menopause in women, as well as stress, cause hormonal changes 
that lead to oversensitive gums, making them more prone to infection (Krejci and Bissada, 
2002). Stress, in particular, also causes changes that make it more difficult for the body to fight 
off infection and therefore puts individuals in greater jeopardy for periodontitis (Carpio, 2012). 
A decrease in the amount of saliva in the mouth can also make it more difficult for the 
body to fight off oral infection. Certain medications that inhibit the flow of saliva therefore 
increase the likelihood of periodontitis (Mohire, Yadav, and Gaikwad, 2009). Some medication 
can also cause an abnormally increased rate of gingival tissue growth, which can make it more 
challenging to keep the teeth and gums clean and free of plaque, enabling the progression of 
periodontal disease (Trackman and Kantarci, 2004).  
2.2.4 Medical Conditions Linked to Periodontal Disease 
It is vital for everyone, particularly for individuals with associated risk factors, to swiftly 
address periodontal health issues because they can extend past the oral cavity and lead to adverse 
effects elsewhere in the body. Numerous studies have shown that the chronic inflammatory 
response triggered by the periodontal bacterial toxin can be linked to heart disease. The oral 
bacteria byproducts produced in the mouth during the onset of periodontitis can enter the 
bloodstream, triggering the production of C-reactive protein (CRP) in the liver. Increases in CRP 
levels cause inflammation of the arteries which can lead to blood clots (Anil et al., 2012). The 
blood clots can clog arteries and lead to heart attacks or strokes (Noack et al., 2001). According 
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to a study performed by Noack et al., the positive linkage between CRP and periodontal disease 
might lead to a pathway that associates periodontal disease and the observed higher risk for 
cardiovascular disease in these patients (Noack et al., 2001).   
In addition to cardiovascular disease, periodontitis also plays a role in diabetes, with a 
number of studies being published that support a connection between diabetes and an increased 
prevalence of periodontitis (Enersen, 2011). Diabetes increases the levels of pro-inflammatory 
cytokines from monocytes and leukocytes, cells that take part in immune response, and down 
regulates growth factors secreted from macrophages, another type of immunological cell. The 
conditions produced by diabetes predisposes the patient to chronic inflammation, as well as 
progressive tissue breakdown and diminished tissue repair capacity, allowing the patient to be 
more vulnerable to periodontal infection (Mealey, 2006). The bacteria involved in periodontitis 
can then prompt the secretion of more pro-inflammatory cytokines which lead to alterations in 
the body’s lipid metabolism, furthering the adverse effects caused by diabetes (Iacopino, 2001). 
The bacteria that cause periodontal disease can also produce respiratory diseases. 
Respiratory diseases begin when bacteria from the mouth and throat are inhaled and drawn into 
the lower respiratory tract. The bacteria can then either worsen existing lung conditions, such as 
chronic obstructive pulmonary disease, or begin an infection (Anil et al., 2012). According to the 
American Academy of Periodontology, “Scientists have found that bacteria that grow in the oral 
cavity can be aspirated into the lung to cause respiratory diseases such as pneumonia, especially 
in people with periodontal disease” (American Academy of Periodontology, 2012).  
Another recent discovery of the effects of periodontitis is that pregnant women with 
periodontal disease are more likely to have a preterm, underweight baby (Krejci and Bissada, 
2002).  Infections, including periodontitis should be closely observed in pregnant women since 
they can be a threat to the baby’s health. A study conducted by the Center for Disease Control 
and Prevention concluded that an immune/inflammatory pathway may be responsible for the 
association between these negative pregnancy outcomes and periodontal disease (Abe et al., 
1994). Though there have been varying degrees of studies done between periodontitis and 
various other systemic diseases, it is clearly evident that the chronic inflammation produced by 
periodontal disease can cause affects in the body far from the infection site. 
2.3 Palatal Graft Surgery 
Currently there are various methods used in the treatment of periodontitis. The most 
widely used is palatal surgery, the gold standard; although there is continual research being done 
to develop a tissue engineered graft for the regeneration of gingival tissue (Leve, 2001). The 
palatal graft, also known as the subepithelial connective tissue graft, is widely used in reforming 
gums that have been damaged due to periodontal disease (Leve, 2001).  
The procedure was first introduced by Langer and Langer in 1985 and has been modified 
throughout the years (Harpreet, 2011). The subepithelial connective tissue graft is used to attain 
root coverage when treating receded gums caused by the disease (Leve, 2001). One of the 
advantages of using this type of graft is that the regenerated tissue closely matches the color of 
the tissue that was lost (Shanmugam et al., 2012). A disadvantage of this procedure is the 
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discomfort to the patients because of the additional donor site that has to be prepared. This 
second wound site also increases the amount of pain as well as the risk of infection (Shanmugam 
et al., 2012). 
The three major steps of palatal graft surgery include: cleaning and preparing the infected 
area, preparing tissue to be used as a graft, and suturing the graft into the infected site (Leve, 
2001). In order to prepare the infected area, first the periodontist must pull back the infected 
gums and thoroughly clean the area to remove the disease causing bacteria. To do this, an 
incision is made above the teeth where the infection is present, as can be seen in Figure 4, and 
then the gums are pulled back so that the underlying tissue can be accessed, cleaned, and any 
repairs, such as bone defects, can be fixed (Colgate Toothpaste, 2010).  
 
 
Figure 4: Sucular Incision (Kwan 2010) 
http://www.youtube.com/watch?v=pw-rO2TpLms 
Once the infected area is thoroughly cleaned, the next step is to harvest tissue from the 
roof of the mouth to be used as the graft. As can be seen in Figure 5, two incisions, about 2 mm 
apart, are made in the roof of the mouth (Leve, 2001). The size of the infected area will 
determine the length of the tissue needed from the roof of the mouth. Once the incisions are 
made, the piece of tissue is excised. This tissue is then cut and shaped to the appropriate size to 
fit into the infected site (Leve, 2001). 
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Figure 5: Parallel Incisions Performed on the Palate (Kwan 2010)  
http://www.youtube.com/watch?v=pw-rO2TpLms 
After the piece of tissue from the roof of the mouth has been cut and shaped to the 
appropriate size, the graft is then positioned into the infected site. The piece of tissue that was 
pulled back so that the site could be cleaned is then pulled back down over the inserted graft and 
together, they are sutured into place, as shown in Figure 6 (Leve, 2001). 
 
 
Figure 6: Final Suture Positioning of the Flap (Kwan 2010)  
http://www.youtube.com/watch?v=pw-rO2TpLms 
Although palatal graft surgery is an effective method for treating severe periodontitis, 
there are numerous drawbacks including (Silverstein et al., 1999):  
1. Two surgeries, one at the infected site and the other at the roof of the mouth  
2. Pain from both wound sites 
3. Limited amounts of tissue available from the roof of the mouth to treat the infected 
area  
These drawbacks have led to a need for an alternative graft material. 
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2.4 Alternative Methods for the Treatment of Periodontal Disease 
There are currently several different methods for treating periodontal disease available on 
the market. Some of these methods aim at eliminating the bacteria in the diseased gums while 
other methods focus on restoring the gum tissue surrounding the tooth. This section discusses 
some of the different methods for treating periodontal disease.  
2.4.1 Atridox™ 
Atridox
™
 is the trademark adopted by the Atrigel
®
 delivery system after it was approved 
by the FDA for sale on the market. The delivery system is manufactured by Atrix Laboratories in 
Fort Collins, CO and consists of 10% doxycycline hyclate which is used as an anti-microbial 
(Scwach-Abdellaoui, Vivien-Castioni, and Gurny, 2000). Atridox
™
 was designed as an injectable 
delivery system which is introduced into the periodontal pocket in order to combat disease 
causing bacteria by interrupting protein synthesis. Although Atridox
™
 has been shown to work 
effectively in these localized pockets, it is difficult to use when treating severe periodontitis due 
to the increased recession of the gingival tissue (Tenenbaum, 2005). 
2.4.2 Photodynamic Therapy 
Another method that uses an anti-bacterial approach to treating periodontitis is 
photodynamic therapy (PDT). PDT utilizes a sensitizing dye which kills bacteria when activated 
by visible light (Meisel and Kocher, 2005). Unlike products like Atridox
™
 that are meant for 
more localized therapy, PDT has the capability of treating a larger diseased area. It also has an 
advantage because it can affect bacteria that have become resistant to drugs and may even 
decrease the rate at which many of the oral disease causing bacteria are becoming resistant to 
anti-microbial drugs (Chan and Lai, 2003). Although photodynamic therapy can combat the 
bacteria that lead to the progression of the disease the specificity of the therapy is still in question 
and studies are still being conducted to ensure that PDT doesn’t affect host cells (Hamblin and 
Hasan, 2004).   
2.4.3 AlloDerm® 
The major drawback of the treatment methods described above is their inability to aid in 
the regeneration of the lost gingival tissue. Currently, the only alternative to flap surgery’s 
autologous graft being used during treatment to support the regeneration of tissue is AlloDerm
®
 
(A. Lee, DMD, personal communication, October 2, 2012). AlloDerm
®
 is an acellular dermal 
matrix obtained from human cadavers manufactured by LifeCell. It is manufactured using 
proprietary methods that remove the cells, leaving behind a matrix primarily made up of collagen 
(AlloDerm
®
, 2012). An in vitro study conducted by Rahmani and Lades compared the use of the 
autologous graft against a decellularized dermal matrix for treating gum recession. The study 
concluded that there was no significant difference between the successes of the two treatments 
and that the decellularized dermal matrix seems to be the most advantageous of the methods 
since it can provide the same treatment without the drawbacks presented through the harvest of 
the autologous graft (Rahmani and Lades, 2006). Although promising, AlloDerm
®
 presents its 
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own limitations, particularly due to handling. AlloDerm
®
 is a much more difficult material to 
handle due to its low mechanical stability and has been found to tear easily when being placed 
into the infected site (Saadoun, 2008). 
2.4.4 Gintuit™ 
 Organogenesis Inc., a company located in Massachusetts, has made the only cellularized 
product currently approved by the United States Food and Drug Administration (FDA) for the 
regeneration of gingival tissue. According to Organogenesis Inc., “Gintuit™ is a thin cellular 
sheet made of human fibroblasts, keratinocytes, human extracellular matrix proteins, and bovine 
collagen” (Gintuit™, 2012).  It was previously marketed as Apligraf® for the regeneration of 
dermal tissue, but was also found to be applicable in the regeneration of oral tissue (Food and 
Drug Administration, 2012).     
Organogenesis completed a series of randomized clinical trials to evaluate the efficiency 
and safety of Gintuit™ “when used to regenerate soft gum tissue in patients with gingival 
recession” (Gintuit™, 2012). The results showed that Gintuit™ was able to generate keratinized 
gum tissue that closely matched the color and texture of the patient’s own tissue. Patients 
preferred Gintuit™ over the palatal graft surgery because there was only one surgical site, which 
led to a more comfortable recovery (Food and Drug Administration, 2012). The results of the 
clinical trials showed that Gintuit™ was considered safe enough to use in the mouth although 
there were some common adverse reactions experienced during its use (Food and Drug 
Administration, 2012). Some of the adverse reactions of Gintuit™ included: “sinusitis, 
nasopharyngittis, respiratory tract infection, apthous stomatitis, and the local effects of oral 
surgery” (Food and Drug Administration, 2012). Gintuit™ was also found to be difficult to 
handle by periodontists because it is circular and it would have to be folded or cut into a 
rectangular shape to better fit the infected site (Food and Drug Administration, 2012). Therefore, 
the limitations of Gintuit™ prove that there is a need for artificial gum tissue in the treatment of 
periodontitis that can be more easily handled by dental professionals. 
2.5 Guided Tissue Regeneration 
 In order to efficiently regenerate tissue during wound healing it is often beneficial to 
guide cells to the wound site so that they can synthesize the necessary extra cellular matrix. This 
can be accomplished through the use of scaffolding with pores appropriate for cell migration.  
2.5.1 Gore® BIO-A® Tissue Reinforcement 
Gore
®
 BIO-A
®
 Tissue Reinforcement is manufactured by W.L. Gore & Associates, Inc. 
as part of a product line for Gore: Creative Technologies Worldwide (W.L. Gore & Associates, 
2012).  Gore
®
 BIO-A
®
 is a fully synthetic graft, lacking any products derived from living tissue. 
The graft is made up of a web of resorbable biocompatible polymers, 67 percent polyglycolic 
acid (PGA) to 33 percent trimethylene carbonate (TMC), which can be absorbed into the body as 
its three dimensional open pore matrix facilitates the growth of tissue and healing at the 
application site (Massullo et al., 2012). The reabsorption process takes place gradually over six 
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months. During this time cells from the surrounding area penetrate the matrix and replace the 
polymers with vascularized soft tissue (W.L. Gore & Associates, 2012). A study conducted by 
Zemlyak et al. demonstrated the histological results obtained after subcutaneously implanting 
Gore
®
 BIO-A
®
 Tissue Reinforcement in rabbits and harvesting the grafts at 7, 14, 30, 60, 90, and 
180 days. Gore
®
 BIO-A
®
 Tissue Reinforcement showed enhancement of cellular in-growth 
between the samples tested at day 7 and day 30 (Zemlyak et al., 2012). In a study conducted by 
Zemlyak et al., Gore
®
 BIO-A
®
 demonstrated a large amount of tissue in-growth and type I 
collagen deposition at day 30 after the material was implanted (Zemlyak et al., 2012).  
Gore
®
 BIO-A
®
 was designed for the reinforcement of soft tissue and is used in 
applications such as hernia repair (W.L. Gore & Associates, 2012). The team believes that this 
product would be suitable for the purpose of this project because it is biodegradable so it will be 
completely replaced by gingival tissue. This graft is particularly suitable because it promotes the 
growth of vascularized soft tissue and vascularization is an important aspect of the tissue 
surrounding the teeth. Due to the lack of living tissue components, Gore
®
 BIO-A
®
 does not put 
the patient at risk of human or animal source contamination, increasing its biocompatibility. The 
graft is also easy and less expensive to store since it does not require any special care and can be 
manufactured in greater quantities because of an extensive shelf life (W.L. Gore & Associates, 
2012). 
2.6 Cells to Promote Gingival Regeneration 
In order to create the best type of synthetic graft possible, the idea of seeding the graft 
with different cell types and in different combinations could possibly yield better results for 
patients inflicted with periodontitis. A variety of cell types that could help regenerate diseased 
tissue were investigated including: fibroblasts, keratinocytes, cementoblasts, periodontal 
ligament cells, and periodontal ligament stem cells.  
2.6.1 Fibroblasts 
Fibroblasts are found in every tissue throughout the body and are the most common cells 
found in connective tissue (Baum and Duffy, 2011). They synthesize the extracellular matrix that 
maintains the structure of connective tissues, produce collagen, and promote wound healing. 
Like all connective tissue cells, fibroblasts originate from the mesenchyme. While their size 
varies, they are roughly 10-20 microns wide and are usually found grouped together (Baum and 
Duffy, 2011). They can either be in an active state or inactive state. In the active state, they 
contain a large amount of rough endoplasmic reticuli and in their inactive state they are much 
smaller and contain fewer endoplasmic reticuli, which changes their morphology to be much 
thinner and stretched out (Ravikanth et al., 2011). Because they are found in so many different 
places in the body, their appearances differ depending on their location and what activity they are 
performing. When transplanted, fibroblasts tend to maintain their “positional memory” of not 
only the location but also the tissue type that they were taken from (Baum and Duffy, 2011).  
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2.6.2 Keratinocytes 
Keratinocytes are the primary cells of the epidermis. They produce keratin, which is a 
protein secreted in the hair, nails, and skin to provide these structures with toughness to protect 
from tearing and to create a barrier between the body and the invading agents in the surrounding 
environment (Marieb, 2013). Keratinocytes can be between “6-70 times stiffer” compared to 
other cell types in the body (Lulevich et al., 2010). They usually exist at an average size of 20 
microns (Barrandon and Green, 1985). In addition to being a major component of the skin, 
keratinocytes are also found in the oral mucosa to provide a keratinized surface for the gums, 
making them tougher and more resistant to abrasion (Squier and Kremer, 2001). 
2.6.3 Cementoblasts 
Cementoblasts are cells that produce cementum. Cementum is a type of mineralized 
tissue, which surrounds the entire root of a tooth (Bosshardt, 2005). The main function of 
cementum is to attach the tooth to the periodontal ligament, which anchors the tooth in the 
jawbone. Cementoblasts are found within the periodontal tissue including the periodontal 
ligament (Bosshardt, 2005). 
2.6.4 Periodontal Ligament Cells 
The periodontal ligament is made up of a group of collagen fibers that attach the tooth to 
the jawbone (Listgarten, 2012). Multiple preliminary studies have evaluated how well cells taken 
from the periodontal ligament (i.e. periodontal ligament (PDL) cells), which have been cultured 
in vitro, treat and regenerate infected periodontal tissue. A summary of these studies, compiled 
by Benatti et. al, explains the findings and the role of PDL cells. It was demonstrated that 
periodontal ligament cells are capable of “preventing epithelial downgrowth and root resorption” 
as well as promoting the formation of cementum and alveolar bone, although this occurred at 
varying degrees of formation and was not always successful (Benatti et al., 2007). These cells 
have also been found to be fibroblast-like and produce collagen (Benatti et al., 2007). 
2.6.5 Periodontal Ligament Stem Cells 
In a 2004 study by Seo et al., associated with the National Institute of Dental and 
Craniofacial Research, periodontal ligament stem cells (PDLSCs) were isolated from the 
periodontal ligament of human third molar teeth, commonly known as the wisdom teeth (Seo et 
al., 2004). PDLSCs are fibroblast-like and are characterized by their ability to give rise to 
collagen. In addition to collagen, they have been found to be capable of developing into 
adipocytes, osteoblasts, and cementoblast-like cells in vitro. They were also found to have the 
ability to produce “cementum-like and periodontal ligament-like” tissues in vivo (Seo et al., 
2004). Also in this study, PDLSCs were assessed on whether or not they would be able to 
contribute to periodontal tissue repair. After transplanting PDLSCs into rats with compromised 
periodontal tissue, it was found that they have the potential to aid in periodontal tissue 
regeneration (Seo et al., 2004). 
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Chapter 3: Project Strategy 
The goal of this project is to design an artificial graft that will aid in the regeneration of 
gum tissue in order to treat periodontitis. The project team conducted an extensive literature 
review using a variety of journal articles to gain a better understanding of periodontal disease 
and how it is currently being treated. The team researched grafting methods for other parts of the 
body that may be able to be adapted to the mouth environment. Upon gathering the appropriate 
information from the literature review and an interview with a periodontist, the team formulated 
a list of objectives and constraints for this device. The objectives were ranked by the team and 
the metrics were developed to evaluate whether or not each objective was successfully met. The 
objectives and constraints enabled the project team to develop a list of functions that the graft 
must perform, as well as means for achieving these functions. These functions and means 
allowed us to generate alternative designs for the graft, all of which are outlined in Chapter 4.  
 
3.1 Initial Client Statement 
The initial client statement, generated by the team, stated:  
 
Though some periodontal diseases can cause simple gum inflammation, more 
severe cases result in major damage to the soft tissue and bone that support the 
teeth. A common periodontal disease is gingivitis which is the inflammation of 
the gums caused by a buildup of plaque and tartar. When gingivitis is left 
untreated, as is the case with the numerous individuals that do not make regular 
dentist visits, it can advance to periodontitis. During the course of this disease the 
gums pull away from the teeth, creating pockets that then become infected. This 
infection then initiates an immune response to fight the bacteria. Due to both the 
bacterial toxins and the immune response, the bone and connective tissue that 
hold the teeth in place begin to break down. (National Institute of Dental and 
Craniofacial Research, 2011)  
 
In order to combat periodontitis, a patient might have to undergo flap surgery 
during which the gums are lifted back so that the tartar may be removed. After 
flap surgery the dentist may utilize tissue grafts to help the regeneration of the 
broken down gum tissue (National Center for Biotechnology Information, 2010). 
The tissue graft could be an autograft that is usually cut from the roof of the 
patient’s mouth, requiring more intrusion and increasing discomfort and healing 
time, as well as the chance for post-operative infection (Powell, 2005). Currently, 
the autograft is the most used method, though through the use of this MQP the 
project team hopes to develop a more suitable synthetic graft for this purpose. 
Though there is some mention of synthetic materials seeded with growth factors 
for the regeneration of gum tissue, there have not been many documented 
advances in the field. Through the use of this MQP, the project team will research 
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various biomaterials that could be suited for use as grafts as well as the optimal 
growth factors for this application. This research will lead to the development of a 
possible prototype for a synthetic gum graft.   
   
It would be important to develop a cheaper and better gum graft for use in 
periodontal surgery because advanced gum disease affects 4 to 12% of adults 
(Gum Tissue Grafts, 2012). Gum disease can affect other areas of the body 
besides the mouth. Studies have linked gum disease to an increase in likelihood 
for developing heart disease as well as diabetes (National Institute of Dental and 
Craniofacial Research, 2011). 
 
3.2 Objectives and Metrics 
As previously mentioned, the goal of this project is to create an artificial graft that may be 
utilized in the mouth in the future treatment of periodontal disease. Based upon the team’s initial 
client statement and research of published literature, the team developed the following main 
objectives for the device:  
 Allow cell infiltration and cell adherence 
 Promote collagen deposition 
 Demonstrate mechanical stability 
Allow cell infiltration and cell adherence: The scaffold must allow the cells to infiltrate and 
adhere to the scaffold. The adherence of cells would allow more collagen to be produced while 
the uniform distribution would allow a layer of collagen to form that more closely mimics the 
mucosal layer of the mouth.   
 
Promote collagen deposition: It is essential to develop a graft that promotes collagen 
deposition. The graft must promote collagen deposition because it is one of the main components 
of the gingival tissue that is lost due to periodontitis.   
 
Demonstrate mechanical stability: The device should possess mechanical properties similar to 
current products used on the market, such as AlloDerm
®
. This will ensure that the graft can be 
handled by periodontists without tearing or breaking. Ultimately, mechanical properties better 
than those of AlloDerm
®
 would be ideal in order to create a better graft.  
 
To better understand and organize all of the objectives, the team created an objectives 
tree complete with main objectives and corresponding sub-objectives (Appendix B). The team 
also developed a Pairwise Comparison Chart (PCC) in order to rank the objectives in terms of 
importance. The summary of our PCC can be seen in Error! Reference source not found. and 
our PCC is included in Appendix C.  
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Foremost, the graft must be able to promote collagen deposition. The device should also 
allow cell infiltration and cell adherence. These two objectives are most important. Without 
promoting collagen deposition the graft would be unable to mimic the properties of the mouth. 
Also, if the cells do not adhere and infiltrate the scaffold, the graft would not be able to integrate 
into the surrounding tissue when placed in the mouth. The mechanical properties of the scaffold 
must be equal to or better than the current benchmark, AlloDerm
®
, in order to provide a more 
attractive option for treatment of periodontitis. The graft will be considered a success if all of the 
objectives are met.   
 
Table 1: Pairwise Comparison Chart with Team Weighted Scores 
Objectives Team’s Score Weighted 
Promote collagen 
deposition 
2 67% 
Allow cell infiltration and 
cell adherence 
 
1 33% 
Possess mechanical stability 0 0% 
 
After all of the objectives were ranked, it was important to make sure that each objective 
had corresponding metrics to determine what constitutes the success of the graft in achieving 
each objective. The metrics were mainly derived from the team’s research of tissue engineering 
literature on already approved graft testing. The following metrics were developed for each 
objective: 
Objective: Allow cell infiltration and cell adherence 
Metrics:  
 There must be an increase in cell adherence over each time period  
o The amount of cells was qualitatively determined using a Hoechst stain at days 3, 
7 and 14.  
 Scaffold must be a suitable environment for cells to grow and infiltrate the scaffold 
leading to a uniform cell distribution over time 
o A Harris hematoxylin and eosin stain was used to visualize the infiltration of cells 
at days 3 and 14.  
 
Objective: Promote collagen deposition  
Metrics: 
 Cells must be able to deposit collagen on the scaffold and an increase in collagen 
deposition must be seen over time 
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o Collagen was visualized using a picrosirius red/fast green stain at days 3 and 14 
  
Objective: Possess mechanical stability 
Metrics: 
 The scaffold must have similar mechanical properties of the current benchmark graft, 
AlloDerm
®
 
o The elongation to failure and stiffness of the scaffold was measured and compared with 
AlloDerm
®
 to ensure that it could be stretched and elastically deform under a 
larger force than AlloDerm
®
 without breaking  
 Must be able to maintain mechanical properties of scaffold after hydrating in complete 
medium, which would eventually be used to keep the cells viable in a clinical setting 
 
In order for the team to make the device as efficient, or more efficient, than the allografts 
already used by dental professionals in place of the autologous graft, the team must fulfill all of 
these objectives.  
3.3 Constraints 
Along with project objectives, the project team also developed constraints for the project 
to allow the team to better define the client statement. Three of the most limiting constraints in 
this design process are time, budget, and biocompatibility. The project must be completed for 
Project Presentation Day on April 18, 2013. Also, the team has a limited budget and must keep 
this in mind when choosing a design. The total allotted budget for this project is about $450. 
Additionally, the graft must be biocompatible otherwise it could not serve a clinical purpose.  
3.4 Hypothesis 
Aside from the design component, the project team will also asses the hypothesis that 
oral connective tissue fibroblasts will contribute to the deposition of gingival tissue-specific 
extracellular matrix, particularly collagen, suitable for oral surgical application. 
3.5 Revised Client Statement 
After gaining extensive knowledge of periodontitis, as well as how it is currently treated 
and various methods of tissue regeneration, the project team was able to develop applicable 
objectives, constraints, and design metrics for the production of a synthetic graft. These design 
guidelines were then used to create an updated client statement that is more specific to the 
design. The revised client statement is as follows: 
 
“The goal of this project is to design a biocompatible synthetic graft for use in the 
treatment of periodontitis. The graft must guide regeneration of gingival tissue that has 
receded due to periodontal disease in order to prevent attachment loss between the 
gingiva and the teeth. It must be low cost (less than $450 to manufacture and test based 
on project budget) and easy to manufacture. The graft must then be able to function with 
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the cells in tissue regeneration. The graft must allow for natural, uniform growth of tissue 
resembling the natural tissue found in the mouth. The design must be easy for 
periodontists to use, meaning that it must be able to resist tearing and be able to withstand 
suturing.” 
 
This revised client statement helped the project team define the problem and the goals for 
the overall design so that progression into design development could be made. 
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Chapter 4: Design Alternatives 
 In order to formulate and evaluate different design alternatives, the project team first 
determined the functions and specifications that a graft would have to meet in order to regenerate 
gingival tissue as well as perform in a manner equal to, or better than AlloDerm
®
. Using these 
functions and specifications, the project team devised a total of three different design alternatives 
4.1 Functions and Specifications  
 The overall goal of the team’s design is to create a graft from a scaffold that can be used 
for the treatment of periodontal disease. In order to accomplish this, the graft must function in a 
way that enables the growth of soft gingival tissue. The function considered for this design and 
the means through which they could be achieved are outlined in the functions/means chart shown 
in Appendix M. The specifications that stem from this primary function are involved in the 
promotion of soft tissue growth. The graft must stimulate collagen deposition since this is the 
major extracellular matrix that makes up gingival tissue.  
4.2 Alternative Designs  
 In order to meet the project goal, the team considered multiple designs aimed at creating 
an alternative graft that would mimic the cellular and mechanical properties of gum tissue.   
4.2.1 Synthetic Scaffolding 
 One of the design alternatives formulated by the team was using a synthetic scaffold as 
the graft. The first option for attaining the synthetic scaffold had been to synthesize a polymer 
blend and manufacture the graft on site. Due to time and budget constraints, this was not a 
feasible option. Instead the team chose to repurpose synthetic scaffolding that had previously 
been approved by the U.S. Food and Drug Administration (FDA). In order to do so, the team did 
an extensive market and literature review to find a biodegradable material that could meet the 
functions and specifications while working within the constraints of this project. The synthetic 
scaffold used would serve in guiding the surrounding cells into the diseased area, allowing them 
to repopulate the wound site and synthesize the extracellular matrix necessary for the 
regeneration of tissue. Using a commercialized synthetic scaffold without any living components 
could allow the design to have a long shelf life without any particular storage constraints. On the 
other hand, the lack of new cells being introduced into the wound site, such as the cells 
introduced when the graft is taken from the palate, could indicate a slower healing time causing 
more inconvenience and discomfort to the patient.  
4.2.2 Synthetic Scaffold Seeded with Cells 
 Another design alternative consisted of utilizing a commercially available synthetic 
scaffold and populating it with cells that would deposit collagen. Utilizing the cells would enable 
the scaffold to more closely mimic the conditions of the palatal graft currently used in treating 
periodontal disease. The healing time could in fact shorten if the deposition of collagen is made 
optimal by using an efficient cell density when seeding the scaffold. Though promising, using a 
scaffold pre-seeded with cells presents some potential difficulties. It would have a decreased 
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shelf life, which could make distribution difficult. It would also require special storage 
conditions in order to keep the cells viable. In terms of the project team’s in vitro approach for 
design validation, it may be difficult to get the cells used to adhere to the scaffold even if the 
scaffold has the correct pore size for cell mobility and has been previously used as a graft for 
tissue regeneration.  
4.2.3 Decellularized Matrix             
 The third and final design alternative devised by the project team was using a natural 
decellularized matrix. The matrix would be grown as a monolayer from collagen secreting cells, 
then the cells would be removed leaving the extracellular components to act as a scaffold. If the 
project team did choose to work with a decellularized matrix it would still be difficult to 
ascertain the biocompatibility of the scaffold because, although the components of the 
extracellular matrix have been found to be tolerated well when transplanted, the method used to 
remove the cells from the matrix has the potential to affect the matrix biochemical composition, 
ultrastructure, and mechanical behavior (Gilbert, 2006). These changes could lead to unexpected 
tissue responses when the scaffold is placed into the mouth. The uncertainty of the mechanical 
behavior could also lead to a scaffold that is not strong enough to be handled without ripping or 
sutured into the infected site causing it to be an unattractive option for periodontal use. 
4.3 Numerical Evaluation Matrix 
A numerical evaluation matrix for the potential designs is shown in Table 2. The 
numerical evaluation matrix is being used to evaluate how well the alternative designs meet the 
design objectives. This chart shows both the constraints and project objectives in the left-hand 
column, while the scores assigned to each objective are shown in design-specific columns on the 
right. It should be noted that all of the designs are hindered by the constraint that the graft must 
be biocompatible. 
  
Table 2: Numerical Evaluation Matrix of Design Alternatives 
Design 
Constraints (C) 
and Objectives 
(O) 
Synthetic 
Scaffolds 
Seed Synthetic 
Scaffold with 
Cells 
Decellularized 
Matrix 
C: Biocompatible x x x 
C: Time    
C: Budget    
O: Promote Soft 
Tissue Growth 
60 90 40 
O: Easy to Use 70 60 40 
O: Easy to 
Manufacture 
90 80 20 
TOTALS 220 230 100 
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The synthetic scaffold seeded with cells received the highest score, followed by the 
synthetic scaffold, and the decellularized matrix, respectively. The scoring was based on a scale 
of 10-100 with 100 being the best score and 10 being the worst, and the designs were ranked 
according to how well they would meet each objective. The designs were ranked based on the 
literature found for each scaffold design and the advantages and disadvantages of each type, as 
well as the team’s ability to create or obtain the scaffolds. Seeding a synthetic scaffold with cells 
seems to be the most viable design because the team believes it would be the best at promoting 
cell proliferation if it were used in soft tissue repair in the gums. 
4.4 Conclusion 
Based on the numerical evaluation matrix, the project team chose to seed synthetic 
scaffolds with cells in order to reach the goal. It appears to be the best design in terms of 
promoting collagen deposition as well as cell infiltration. Additionally, it is predicted that it will 
be relatively easy to handle and easy to produce. During the testing of this device the team will 
determine how well the cells infiltrate and populate the scaffold. Mechanical tests will also be 
conducted in order to determine the strength of this design.  
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Chapter 5: Methodology for Validation 
After a synthetic scaffold seeded with cells was chosen as the final design, the project 
team conducted several cellular and mechanical tests by utilizing Gore
®
 BIO-A
®
 as the scaffold 
material. Human gingival connective tissue fibroblasts (hGCF) were chosen as the cell type to 
seed on the scaffold based on the literature review.  
5.1 Cell Culture 
Human oral connective tissue fibroblasts, derived from human gingival tissue, were 
thawed and cultured in Dulbecco’s Modified Eagle’s Medium (DMEM culture medium) 
(Mediatech) and Ham’s F12 (Mediatech). This was supplemented with 10% fetal bovine serum 
(FBS) (Hyclone), gentamicin 50 μg/mL, 50 units/mL of penicillin and streptomycin, and 4 mM I 
glutamine. The cells were incubated in media at 37°C and 5% CO2. A full cell culture protocol is 
shown in Appendix E. 
5.2 Counting Cells 
In order to determine cell seeding protocols, cell counts were needed. Knowing the 
number of cells present in a culture was essential. To obtain a cell count, a 10 μL sample from 
the cell suspension was added to a hemocytometer. A hemocytometer is a counting chamber 
containing an etched on grid. The number of cells present in the four corner squares were 
counted, averaged, and used to calculate the number of cells/mL and subsequently calculate the 
total number of cells in the cell suspension. The protocol used for counting cells is shown in 
Appendix E. 
5.3 Preliminary Testing 
 Before seeding the final experimental setup, a number of preliminary tests were 
performed to test how well the human gingival connective tissue fibroblasts would adhere to 
Gore
®
 BIO-A
®
. In the first test, two 5mm x 5mm x 1.7mm pieces of Gore
®
 BIO-A
®
 were cut 
using a scalpel and a ruler. Once the pieces were cut, they were placed into a four well plate that 
was coated with 500 μL 2% agarose in DMEM, to prevent the cells from adhering to the bottom 
of the well, with 1 mL of cell suspension containing 375,000 cells. The scaffolds were incubated 
with cells for 48 hours. The second trial involved cutting two pieces of Gore
®
 BIO-A
®
 at 5mm x 
5mm x 1.7mm and adding them to a four well plate coated with 250 μL of agarose. This time, 
the scaffolds were soaked in 500 μL of complete medium overnight. The next day, the medium 
was aspirated off the scaffolds and 1 mL of cell suspension (375,000 cells) was added to each 
and left to incubate for 48 hours. For the third trial, two pieces of Gore
®
 BIO-A
®
 were cut at 
3mm x 2mm x 1.7mm and coated with collagen I bovine (1 mg/mL) overnight. The next day, the 
scaffolds were added to wells coated with 100 μL of agarose and containing 100 μL of media 
and incubated for 48 hours. 48 hours later, the media was aspirated off and 50 μL of cell 
suspension was added.  
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5.4 Cutting Gore® BIO-A® for Experimentation 
 For the final experiment, a total of 24 pieces of Gore
®
 BIO-A
®
 were cut at 2mm x 2mm x 
1.7 mm each using a scalpel and a ruler, both of which were sterilized using 70% ethanol. After 
cutting, the pieces were stored in a sterile 10 cm petri dish until they were needed for 
experimentation.  
5.5 Experimental Set-up 
 In order to set-up the experimentation process, a 96 well plate was utilized. Three rows 
were used, one for each time point (Day 3 after seeding, Day 7 after seeding, and Day 14 after 
seeding), and four columns each, three in which cells would be seeded onto the scaffolds (one to 
be used for histology, one to be used for a Hoechst stain, and one extra to be used if necessary) 
and one without cells to act as the control. The plate was also divided in half so as to 
accommodate the two different seeding techniques. Figure 7, below, is a digital image of the well 
plate that was used throughout the experiment, showing exactly how it was set-up. Before 
placing the cells, media, or scaffolds into the wells, 100 μL of agarose was used to coat the 
bottom of the wells that would be utilized in order to prevent the cells from adhering to the 
bottom of the plate and therefore increasing the chances that they would adhere to the scaffold. 
 
 
Figure 7: Digital image of the set-up of the 96 well-plate used for the experiment depicting the time point, the seeding 
style, and whether of nor cells were seeded onto the scaffold or not 
5.6 Collagen Coating 
 Because the fibroblasts did not adhere to the Gore
®
 BIO-A
®
 alone in the preliminary 
trials, coating the scaffold with a substance that the cells might be more likely to adhere to was 
tried. Because fibroblasts produce collagen, a collagen I bovine coating, at a concentration of 1 
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mg/mL, was utilized. A 1:2.125 dilution of the collagen I was made with phosphate buffered 
saline (PBS). Each scaffold was placed in a well of a 96 well plate and 100 μL of the collagen 
coating was added to each. Once the collagen I was added, the plate was sealed and stored in a 
cold room overnight.  
5.7 Soaking in Media 
 After the scaffold had soaked in the collagen coating for 24 hours, the collagen coating 
was then replaced by the addition of complete medium. To do this, the remaining liquid of the 
collagen coating was aspirated out of the well and 100 μL of complete medium was added to 
each scaffold. This step allows the scaffold to equilibrate to the media environment that the 
fibroblasts are cultured in. It also acts as a sterilization step because the media contains 
antibiotics that can kill any bacteria present on the scaffold before introducing the cells. Once the 
scaffolds were soaking in media, they were then incubated at 37°C and 5% CO2 for 48 hours.  
5.8 Seeding 
 For the preliminary testing, the cells were seeded onto each scaffold at a density of 
375,000 cells/mL and the fibroblasts were directly seeded onto the scaffold, meaning that 1 mL 
of the cell suspension was added directly on top of the scaffold. For the final experiment, 
375,000 cells/50 μL were seeded onto each scaffold using the direct seeding technique. 50 μL of 
cell suspension was added to each scaffold. A method of indirectly seeding the cells onto the 
scaffold was also used in order to determine if one method would be better than the other. The 
indirect seeding technique involved adding 50 μL of cell suspension to the well first and then 
adding the scaffold, in the hopes that the cells would migrate into the scaffold.  
5.9 Maintaining the Scaffolds throughout Testing 
 In order to maintain the scaffolds throughout the experimental process, media was added 
every couple of days in order to ensure that the scaffold would not dry out. Also, the media was 
changed every four days so that the nutrients in the media did not become fully exhausted. 
5.10 Adhesion Technique 
 Initially during the preliminary tests, the project team wanted to determine how many 
cells adhered to the scaffold after 24 hours post seeding. To do this, the scaffold was washed 3 
times with PBS to wash non-adherent cells off the scaffold. Next, the scaffold was trypsinized to 
get the adherent cells to dissociate from the scaffold. The cells were then collected and stained 
with trypan blue in order to count the number of live versus dead cells. This technique did not 
produce substantial data and because of this it was not used for the final experiment. 
5.11 Fixing the Scaffolds 
 In order for the team to perform histology tests on the scaffolds, first the scaffolds had to 
be fixed at the correct time points, and only day 3 after seeding, and day 14 after seeding were 
used. In order to do this, on the appropriate time point, each scaffold was removed from the 96 
well plate and placed in 1 mL of 10% neutral buffered formalin for an hour. Once the hour was 
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up, each scaffold was transferred to 1 mL of 70% ethanol until processing and staining could be 
performed. 
5.12 Hoechst Stain 
 Due to the poor data obtained using the adhesion technique explained above, a Hoechst 
stain was performed instead, allowing the team to observe the presence of cells in and on the 
scaffold. The scaffolds from each time point and the controls were stained by diluting the 
Hoechst staining solution to a concentration of 10 mg/ml in PBS. Each scaffold was placed into a 
well in a 12 well plate. 1 mL of staining solution was added to each well. Once the scaffolds 
were covered with staining solution, they were incubated for 30 minutes at room temperature in a 
dark place, in this case completely covered with tinfoil. After the 30 minutes, the scaffolds were 
imaged using an inverted microscope and viewed under fluorescence. The amount of cells 
present on the scaffolds from each time point was qualitatively shown because the Hoechst stain 
stained the fibroblast nuclei blue. The relative amount of cells present on each scaffold was 
compared to each time point.  
5.13 Final Experimental Procedure 
For the final experiment, a total of 24 pieces of Gore
®
 BIO-A
®
 were cut at 2mm x 2mm x 
1.7 mm each. Scaffolds were soaked in 100μL of 1mg/mL bovine type I collagen (Advanced 
BioMatrix PureCol) for 24 hours in a 96-well plate. After collagen coating, the scaffolds were 
transferred to a new 96-well plate with the bottom of each well coated in 2% agarose in DMEM, 
in order to prevent the cells from adhering to the bottom of the plate as well as encourage the 
cells to adhere to the scaffold. The scaffolds were pre-incubated in 100μL of complete medium 
for 24 hours prior to any cell seeding in order to make sure the scaffolds were fully equilibrated. 
After equilibration in complete medium, hGCFs were seeded onto the scaffolds.  
The scaffolds were incubated until the time points were reached. At each time point, the 
respective scaffolds were fixed in 10% neutral buffered formalin for an hour and then placed in 
70% ethanol overnight. The scaffolds to be used for histology were then embedded into a mold 
with agarose before being processed and embedded with paraffin as determined by the 
methodology developed in Appendix L. Once set, the scaffolds were sectioned to a thickness of 
6 μm and placed onto slides coated with poly-L-lysine which were then left to dry overnight. 
After 24 hours the slides were stained in a horizontal orientation with either a hematoxylin and 
eosin dye or a picrosirius red/green dye. The remaining scaffolds, aside from the extras, were 
then stained with 1 mL of the Hoechst stain solution at a concentration of 10 mg/ml and left to 
incubate for 30 minutes at room temperature in the dark (covered with tinfoil). After the 30 
minutes, the scaffolds were imaged using an inverted microscope under fluorescence in order to 
be able to view the nuclei of the cells present on and in the scaffold. 
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Chapter 6: Results and Discussion 
6.1 Objective: Allow Cell Infiltration and Cell Adherence 
In order for the scaffold to be used as a gingival graft, the cells must show that they have 
infiltrated and adhered to the scaffold uniformly. To test how well the cells on the scaffold met 
this objective, a Hoechst stain was performed, in which the scaffold was stained and imaged at 
each time point, as described above. Seeded scaffolds were compared to unseeded controls. 
Figure 8 shows images of the unseeded control Gore BIO-A scaffolds dyed with Hoechst stain at 
a concentration of 10 mg/ml and taken in brightfield (left) and under fluorescence (right) at 
objective 10X. These images show what the scaffold normally looks like. The fibers making up 
the scaffold can easily be observed. The image on the right indicates that the scaffold auto-
fluoresces blue.  
 
 
Figure 8: Digital images of the unseeded control Gore® BIO-A® scaffolds stained with Hoechst stain and viewed with an 
inverted microscope in brightfield (left) and under fluorescence (right) at objective 10X at day 14. Scale bar = 50 microns 
 In addition to testing how well the cells infiltrated and adhered to the scaffold, two 
different seeding techniques were performed to determine if one resulted in better infiltration and 
more cell adherence. Cells were directly seeded onto one set of scaffolds and indirectly seeded 
onto the other set, as described earlier. Visualization of cell adherence and alignment on the 
fibers was observed by performing a Hoechst stain, which dyes the cell nuclei blue. Figure 9, 
below, depicts the seeded scaffolds at each time point compared to the unseeded control. Figures 
9A and B show the control scaffold in brightfield and under fluorescence as shown earlier. 
Figures 9C, E, and G illustrate the directly seeded scaffolds at each time point, days 3, 7, and 14, 
respectively. Figures 9D, F, and H illustrate the indirectly seeded scaffolds at each time point, 
days 3, 7, and 14, respectively. As can be seen by observing the images, the fibers can still be 
seen, but most importantly the cells can also be visualized. Looking at the day 3 scaffolds, 
Figures 9C and D, it is clear that the directly seeded scaffold contains more cells; however, the 
cells that are present on the day 3 indirectly seeded scaffold seem to be attached to the fibers. By 
day 7, there still appear to be more cells on the directly seeded scaffold compared to the 
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indirectly seeded scaffold. Figure 9E clearly shows more cells on the scaffold and much better 
cell alignment onto the fibers than Figure 9F. Both of the day 7 scaffolds show more cell 
alignment to the fibers than their respective day 3 scaffolds. Figures 9G and H depict the day 14 
directly and indirectly seeded scaffolds, respectively. Even more cells seem to be aligned on the 
fibers of both scaffolds at this time point compared to the previous time points, however the 
directly seeded scaffolds still show more cells aligned to the fibers.  
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Figure 9: Digital images of the seeded Gore® BIO-A® scaffolds (C-H) compared to the unseeded controls (A-B). All 
scaffolds were stained with Hoechst stain and viewed with an inverted microscope at objective 10X. Scaffolds shown in 
images B-H were viewed under fluorescence. Scaffold shown in image A was viewed in brightfield. Indirectly seeded 
scaffolds are shown in images D, F, and H and directly seeded scaffolds are shown in images C, E, and G. Cells appear as 
the brighter blue dots. Scale bar = 50 microns. 
Brightfield A B 
H 
E 
D 
F 
G 
C 
Fluorescence 
Day 3 Direct 
Day 7 Direct 
Day 3 Indirect 
Day 7 Indirect 
Day 14 Direct Day 14 Indirect 
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To test whether the cells were able to infiltrate the scaffold, a Harris hematoxylin and 
eosin stain was used to dye the nuclei of the cells in order to locate them. The results shown in 
Figure 10 are oriented so that the scaffold is to the right and the edge to which the cells initially 
adhered is to the left. The middle of the scaffolds is located at the right edge of the image. The 
results showed that the unseeded control did not contain any cells thereby proving that any cells 
imaged were placed on the scaffold by using either of the project team’s seeding techniques. 
When comparing the indirectly seeded scaffolds to the directly seeded scaffolds in Figure 10 it is 
clear to see that the directly seeded hGCFs were able to travel further within the fibers. Figure 10 
also shows that the cells were most spread out on the directly seeded scaffold imaged at Day 14. 
Unfortunately none of results gathered showed the hGCFs uniformly distributed throughout the 
scaffold with only a few cells on the directly seeded scaffold at Day 3 able to reach the middle of 
the scaffold.    
 
 
Figure 10: Figure depicting images of the Harris hematoxylin and eosin staining with an unseeded scaffold serving as a 
control. All scale bars equal 50 microns except for the phase contrast image of the control. Phase scale bar is equal to 300 
microns. 
6.2 Objective: Promote Collagen Deposition 
 
 Figure 11, shown below, depicts images that were stained with picrosirius red/fast green 
dyes in order to stain collagen red and counterstain the cells green. The results shown are marked 
so that the outline of the scaffold is boxed in and arrows point to areas where collagen deposition 
occurred. An unseeded control was used to provide a collagen baseline since the scaffolds had 
been coated with type I bovine collagen prior to being seeded with the hGCFs. The results 
showed that the cells were unable to produce large quantities of collagen nor were they able to 
provide a uniform collagen layer. Instead, Figure 11 shows there were isolated instances of 
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collagen deposition, particularly along the edges of the scaffolds. When comparing the directly 
seeded scaffolds to the indirectly seeded scaffolds it is clear that the directly seeded cells were 
able to deposit marginally greater amounts of collagen. The greatest amount of collagen 
deposition occurred on the directly seeded scaffold at Day 14 along the edge of the scaffold that 
held the highest concentration of cells.  
 
 
Figure 11: Figure depicting images of the picrosirius red/fast green staining with an unseeded scaffold serving as a 
control. Picrosirius red stains collagen red and fast green is a counterstain that dyed the cells green. All scale bars equal 
50 μm except for phase contrast image of control. Phase scale bar is equal to 300 μm 
6.3 Objective: Demonstrate Mechanical Stability 
All mechanical testing was done using an E1000 ElectroPlus instron machine located in 
Gateway Park at Worcester Polytechnic Institute (WPI). Tests were conducted to demonstrate 
that Gore
®
 BIO-A
®
 had mechanical stability. In order to test the graft’s ability to meet these 
specifications, the team conducted uniaxial tensile testing and suture pullout testing.  
6.3.1 Uniaxial Tensile Testing 
Six samples of Gore
®
 BIO-A
®
 were cut to the following dimensions: 2 cm long x 0.5 cm 
wide x 1.7 mm thick. Six samples were hydrated for 48 hours—three in PBS and three in 
complete medium. These samples were tested using a Uniaxial Tensile Testing Machine and 
stretched under increasing load. Special attention was paid to ensure that the samples remained 
moist throughout the entire test. Specimens were placed between the grips of the machine as can 
be seen in Figure 12. All specimens were preloaded with 1 N. Load to failure was performed by 
stretching the specimens at a rate of 10 mm per minute until failure. Failure was defined at the 
point at which the material ripped completely in two pieces. Bluehill software was used to collect 
data on each specimen.  
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Figure 12: Digital image demonstrating how the samples of Gore® BIO-A® were placed in the tensile testing machine (the 
arrow indicates the location of the scaffold). 
The initial data from the Instron testing machine can be seen in Figure 13 and Figure 14. 
Figure 13 displays the results from the three scaffolds that were hydrated in PBS and Figure 14 
shows the results from the three scaffolds that were hydrated in complete medium. The data from 
Figure 13 does not consistently start at the same value because the gauge length was not reset 
between collecting data between each sample.  Additionally, in looking at the raw data presented 
in Figure 13 and Figure 14 it is hard to determine the better hydrating solution.  
 
Figure 13: Raw data from the Instron testing of the PBS hydrated specimens 
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Figure 14: Raw data from the Instron testing of the media hydrated specimens 
 The reading from the Bluehill software displayed curves of each sample for force versus 
extension. The software also provided information about the maximum extension achieved and 
the force reading at the maximum extenstion. From this data, Microsoft excel was used to 
determine the stress (force/area) and the strain (extension/original length). Cross sectional area 
was calculated as length x width of the face of each sample placed between the clamps on the 
Instron machine. The elastic moduli of the samples were then determined from the stress-strain 
results. A summary of this data can be seen in Table 3 and Table 4.  
 
Table 3: Data summary of the PBS hydrated samples of Gore® BIO-A® 
Sample Length 
(m) 
Width 
(m) 
Force 
(N) 
Area 
(m
2
) 
Extension 
(m) 
Stress 
(Pa) 
Strain Modulus 
(kPa) 
1 0.00582 0.005 31.7 2.91 x 
10
-5
 
0.0129 1090 0.451 2420 
2 0.00874 0.005 27.0 4.37 x 
10
-5
 
0.0126 617 0.694 890 
3 0.00795 0.005 28.8 3.98 x 
10
-5
 
0.0158 724 0.503 1440 
Average        1580 
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Table 4: Data summary of the media hydrated samples of Gore® BIO-A® 
Sample Length 
(m) 
Width 
(m) 
Force 
(N) 
Area 
(m
2
) 
Extension 
(m) 
Stress 
(Pa) 
Strain Modulus 
(kPa) 
1 0.00786 0.005 19.1 3.93 x 
10
-5
 
0.0134 486 0.587 828 
2 0.00809 0.005 27.6 4.05 x 
10
-5
 
0.0118 681 0.686 993 
3 0.00733 0.005 25.7 3.67 x 
10
-5
 
0.0141 700 0.520 1347 
Average        1060 
 
The average modulus calculated for the PBS samples was 1580 kPa and the average 
modulus calculated for the media samples was 1060 kPa. 
Figure 15 shows a comparison between the average ultimate tensile stress, the average 
elongation to failure, the average load at yield and the average load at failure of scaffold 
hydrated in PBS or complete medium. Overall, when the scaffolds were hydrated in PBS, they 
had better results in all categories. However, there was no significant difference between when 
the scaffolds were hydrated in PBS or complete medium. Table 5 summarizes the results of the 
statistical evaluation determined by performing a TTest in Microsoft Excel. A p value of less 
than 0.05 indicated a significant difference.  
 
Figure 15: Graphical representation of the results of the comparison of the average mechanical properties between the 
scaffolds hydrated in PBS and media (n=3) 
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Table 5: Average data summary of Gore® BIO-A® in PBS and media (n=3) 
 
PBS Media TTEST 
Ultimate Tensile 
Strength (MPa) 
2.9 ± 0.252 2.4 ± 0.437 0.150 
Elongation to 
Failure (mm) 
13.7 ± 1.77 13.1 ± 1.18 0.620 
Load at Yield (N) 29.2 ± 2.37 24.1 ± 4.46 0.181 
Load to Failure (N) 15.0 ± 6.61 9.3 ± 1.61 0.274 
  
In a test done by Vural et al., the mechanical properties of AlloDerm
®
 were tested. 
AlloDerm
® 
was preloaded at a force of 1N. AlloDerm
®
 was loaded to failure at a rate of 10mm 
per minute. The average elongation to failure of AlloDerm
®
 was 5.25 ± 0.890 mm. The average 
elastic modulus of AlloDerm
® 
was 20.8 ± 9.05 kPa (Vural et al., 2006). These results are 
summarized in Table 6. In this study, the size of the AlloDerm
®
 samples tested were 4 cm x 1 
cm, with 0.9 to 1.78 mm thickness, which is a bit larger than the sample size the team used. The 
sample size in this study was 2 cm x 0.5 cm with a thickness of 1.7 mm. Overall, Gore
® 
BIO-A
®
 
could be stretched further before breaking and had a much higher stiffness than AlloDerm
®
.  
 
Table 6: Comparison of the average elongation to failure and average elastic modulus of Gore® BIO-A® in both PBS and 
complete medium with AlloDerm® 
 
Sample Type 
Average Elongation to 
Failure (mm) 
Average Elastic 
Modulus (kPa) 
Gore 
®
BIO-A
®
 
hydrated in PBS 
13.7 ± 1.77 1580 ± 772 
AlloDerm
®
 5.25 ± 0.890 20.8 ± 9.05 
 
6.3.2 Suture Pullout Testing  
Six samples of Gore
®
 BIO-A
®
 were cut to the following dimensions: 2 cm long x 0.5 cm 
wide x 1.7 mm. Three samples were hydrated for 48 hours in PBS and three samples were 
hydrated for 48 hours in complete medium. 3-0 silk sutures applied with tapered needles and tied 
in a double square knot configuration. Sutures were placed 5 mm from the short side of each 
piece. Failure mechanics of 6 scaffolds were assessed with the constructs subjected to 1 N of 
pretension using a uniaxial tensile testing machine. Failure was determined as the point in which 
the suture pulled out from Gore
®
 BIO-A
®
 with the suture still intact. Bluehill software was used 
to collect data on each specimen. 
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The failure mechanics of the scaffolds were evaluated using a custom suture pullout test. 
To stimulate fixation of a graft under tension during surgical repair of gum tissue a pretension of 
1 N was applied to the side arms of the machine and pulled at the rate of 60 mm/sec. The 
maximum load before failure, the corresponding elongation at failure and the location of failure 
were noted for each specimen. Failure was defined as the point at which the suture pulled out 
cleanly from the scaffold’s edge. For all statistical analysis, p ≤ 0.05 was considered significant. 
The raw data collected from Bluehill software for the suture pullout test can be seen in Figure 16 
and Figure 17. 
 
 
Figure 16: Raw data from the Instron testing of the PBS hydrated specimens 
 
Figure 17: Raw data from the Instron testing of the media hydrated specimens  
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 All three specimens hydrated in PBS and all three specimens hydrated in complete 
medium failed according to our definition. Thus the sample number for each group is n = 3.  
The averages of the tensile failure properties of the samples subjected to 1 N pretension 
are demonstrated in Figure 18 and in Table 7. Table 7 also shows that there was no significant 
difference, significant being a p value less than 0.05, in the suture pullout mechanical properties 
between the PBS and complete medium hydrated specimens.  
 
Figure 18: Graphical representation of the results of the suture pullout comparison of the average mechanical properties 
between the scaffolds hydrated in PBS and media (n=3) 
 
Table 7: Average data summary of Gore® BIO-A® in PBS and media (n=3) 
 
PBS Media TTEST 
(p value) 
Ultimate Tensile 
Strength (MPa) 
4.3 ± 0.608 4.35 ± 0.527 0.910083 
Elongation to 
Failure (mm) 
18.2 ± 5.108 16.4 ± 5.486 0.704117 
Load at Yield (N) 21.3 ± 3.215 21.5 ± 2.500 0.947085 
Load to Failure (N) 18.3 ± 4.983 18.2 ± 0.764 0.958927 
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Chapter 7: Discussion 
 The validation of the team’s design is not only based on the gathered results, but also on 
the meaning of these results in the context of the project goal. In order for the design to be 
labeled as successful, it must meet the objectives set forth according to the client statement as 
well as take into consideration the far reaching effects that the design could have on various 
aspects of society if it were to ultimately provide results strong enough to allow the alternative 
graft to be released into the global market.  
7.1 Objective: Allow Cell Infiltration and Cell Adherence 
 To visualize the cells within the scaffold and cell alignment on the fibers, the team 
performed Hoechst stains on the seeded scaffolds from all three time points. Comparing the 
scaffolds from each time point, there are various conclusions that can be made. First, it was 
shown that the scaffolds that were directly seeded contained more cells throughout than the 
indirectly seeded scaffolds. Because the direct seeding technique involves seeding the cells 
directly on top of the scaffold, it makes sense that there would be more cells present on this 
scaffold. Since the cells seeded indirectly were not seeded on top of the scaffold, the cells had to 
infiltrate into the scaffold on their own. Second, the cell adherence to the fibers for both the 
directly and indirectly seeded scaffolds increased with each time point. Having the cells adhere 
to the scaffold is particularly crucial. Collagen is the major component in gingival tissue and the 
primary secretion of oral connective tissue fibroblasts. With more cells present and adhering to 
the scaffold, this would mean that theoretically more collagen would be able to be produced. 
Because of the increased adherence to the fibers, this suggests that more collagen should also be 
produced as well. These results show that this objective was met. 
To visualize the infiltration of cells into areas within the scaffold, the team utilized 
histological staining. The project team used a Harris hematoxylin and eosin stain following the 
protocol outlined in Appendix H. The hematoxylin in the dye bound to the cell nuclei and 
allowed the team to image the cells’ locations within the scaffold. In order to prove that Gore® 
BIO-A
®
 is an acellular material and that any cells imaged were introduced to the scaffold 
through seeding the project team stained a control sample of material that had been coated in 
collagen but not seeded with any cells. When imaged at day 14, the results showed that there 
were no cells present in the sample. 
 In order to test whether the seeded cells would be able to travel through the porous Gore
®
 
BIO-A
®
 and infiltrate deeper parts of the scaffold, the team imaged scaffolds that had been 
seeded with hGCFs (human gingival connective tissue fibroblasts) at days 3 and 14 after seeding. 
The images depicted in Figure 10 show that the cells were unable to fully infiltrate the scaffold 
though they did demonstrate the ability to migrate within the fibers, particularly in the area 
highlighted with an arrow in the image of the directly seeded scaffold at day 3. When comparing 
the indirectly seeded to the directly seeded scaffold it is clear to see that the cells that were 
indirectly seeded were not able to migrate as far within the fibers as the directly seeded hGCFs. 
The team believes that this could be due to the possibly decreased efficiency of this seeding 
technique. Overall, the results showed that the cells, though not uniformly distributed throughout 
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the scaffold, were the most distributed on the directly seeded scaffold at day 14 with some cells 
having gone about 100 μm into the scaffold based on the scale bar. 
7.2 Objective: Promote Collagen Deposition 
In order for the scaffold to fulfill its intended purpose, it must mimic the cellular 
properties of gingival tissue. As discussed in previous chapters, collagen is a major component of 
the gingival tissue lost due to periodontitis. As such, collagen is an important component that 
will aid the scaffold in mimicking gum tissue. The project team seeded the scaffolds with 
gingival fibroblasts derived from oral connective tissue in order to introduce a cell type that 
would deposit collagen onto the scaffold which would ultimately lead to increased tissue healing 
when used as a gingival graft. The scaffolds were fixed and stained with picrosirius red/fast 
green at various time points in order to qualitatively visualize the amount of collagen deposited 
on the scaffold over time. As can be seen in Figure 11, the picrosirius red/fast green histological 
stain dyed the collagen red and counterstained the cells green. The unseeded control was stained 
in order to provide a baseline collagen amount since the Gore
®
 BIO-A
®
 material was coated in 
type I bovine collagen prior to being seeded with cells. Imaging the unseeded control allowed the 
project team to differentiate between the collagen coating and the collagen deposited by the cells. 
Overall the results of the testing were not strong since there was very little collagen deposited but 
they can be used to demonstrate that using the cells to deposit gingival tissue specific 
extracellular matrix onto the scaffold is in fact feasible. Figure 11 showed that most collagen 
could be found in areas of the directly seeded scaffold at day 14 where there was the highest 
concentration of cells. This has led the team to believe that with a greater concentration of cells 
as well as allowing the cells more time to culture on the scaffold better results could have been 
obtained. 
7.3 Objective: Demonstrate Mechanical Stability 
Gore
®
 BIO-A
®
 needs to be able to be handled by a periodontist without falling apart and 
it must be able to be sutured into the infected site. In order to test the graft’s ability to meet these 
specifications, the team conducted uniaxial tensile testing and suture pullout testing. The purpose 
of these experiments was to determine whether or not soaking Gore
®
 BIO-A
®
 in PBS or media 
would have an effect on the mechanical strength of the scaffold. Currently, periodontists prepare 
the grafts they use for periodontal treatment by hydrating them in a saline solution. Hence, the 
project team chose to test the effects that hydrating Gore
®
 BIO-A
®
 in PBS would have on its 
mechanical properties. However, since the design calls for living cells, the team also had to test 
the effects that media would have on Gore
®
 BIO-A
®
 which is the component that the graft would 
need to be stored in to keep the cells viable.  This testing is important in determining the viability 
of the design in commercial use. Periodontal professionals will not consider using the graft if 
they cannot easily work with it, thus the team had to test its mechanical strength. 
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7.3.1 Uniaxial Tensile Testing 
A summary of the raw data can be seen in Table 3 and Table 4. The average modulus 
calculated for the PBS samples was 1580 kPa and the average modulus calculated for the media 
samples was 1060 kPa. However, it is evident from the data that each sample greatly varies and 
the calculations for the modulus were quite different for each individual sample. It should be 
noted that all the samples broke in the middle of the sample face placed between the grips. 
Additionally, the samples greatly varied in the cross-sectional areas, so the need existed for more 
consistently shaped samples to be tested.  
To compare the effects that PBS and media had on Gore
®
 BIO-A
®
 the averages were 
calculated for each of the four parameters. The average ultimate tensile stress was conducted to 
determine the maximum stress the scaffold could withstand without breaking. The average 
elongation determined how far the scaffold could be stretched before failure. The average load at 
yield determined the force at which the scaffold began to deform and could not revert back to its 
original position. The average load at yield determined the force at which the scaffold broke. 
Overall, the scaffolds hydrated in PBS had better result in all categories. However a statistical 
evaluation, with a p value less than 0.05 being significant, determined that there was no 
significant difference between the scaffold hydrated in PBS or media. This means that both PBS 
and media would be suitable to hydrate Gore
®
 BIO-A
®
 in before use in treating periodontitis 
without significantly affecting the mechanical properties of the scaffold.  
In order to be successful, the design must at least meet benchmarks set by AlloDerm
®
. 
The project team chose to use AlloDerm
®
 as the benchmark artificial graft because it is currently 
the only alternative to the autologous graft being used in treating periodontal disease. The team 
chose to focus the comparison on elongation to failure and elastic modulus of AlloDerm
®
. 
Comparing the elongation to failure of AlloDerm
® 
and Gore
®
 BIO-A
®
 was important because 
periodontists need to be able to handle the material without it breaking. The elongation to failure 
of AlloDerm
®
 was much smaller than Gore
®
 BIO-A
®
. For the differences to be significant the p 
value must be smaller than 0.05. The team conducted a Ttest in Excel to figure out the p value. 
Thus, the team determined that the difference between Gore
®
 BIO-A
®
 and AlloDerm
®
 
elongation to failure and elastic modulus parameters were significant because the p values were 
0.020 and 0.003, respectively. Overall, the fact that Gore
®
 BIO-A
®
 can be stretched further 
without breaking than AlloDerm
®
 means that it could be handled better by the periodontists 
without breaking. The stiffness of AlloDerm
®
 was much lower than Gore
®
 BIO-A
®
. This means 
that Gore
®
 BIO-A
®
 has a much larger stiffness and therefore can elastically deform under a 
larger force than AlloDerm
®
. However, the extremely high stiffness of Gore
®
 BIO-A
®
 may not 
make it a suitable graft material to be used in the mouth.  
7.3.2 Suture Pullout Testing  
The raw data collected from Bluehill software for the suture pullout test can be seen in 
Figure 16 and Figure 17.The data from Figure 17 does not consistently start at the same value 
because the gauge length was not reset between collecting data between each sample. All three 
specimens hydrated in PBS and all three specimens hydrated in media failed according to our 
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definition. Thus the sample number for each group is n = 3. These mechanical results for the 
suture pullout test are not significant in that the p values for all parameters were much higher 
than 0.05. This means that it did not matter whether Gore
®
 BIO-A
®
 was hydrated in PBS or 
media when force was applied to the suture to pullout it out of the material. This means that the 
suture pulled out at nearly the same conditions no matter what substance it was hydrated in. 
These results are important because the design has cells, fibroblasts, and therefore would need to 
be stored in media to keep the cells viable before clinical use. The team chose to compare the 
effects that media would have on our Gore
®
 BIO-A
®
 scaffold with the effects that PBS would 
have on the Gore
®
 BIO-A
®
 scaffold. The team chose PBS because it is saline based and currently 
periodontists rehydrated the scaffold they use, like AlloDerm
®
, in a saline based solution, like 
PBS.  
The project team chose to conduct a suture pullout out test on Gore
®
 BIO-A
®
 hydrated in 
media or PBS for 48 hours to determine if the mechanical properties of the scaffold could be 
retained when suturing the graft. The team needed to determine that Gore
®
 BIO-A
®
 was a strong 
enough material to withstand the force need for suturing. In a study by Capek et al., the 
maximum force the surgeon used varied from 0.5 N for the smallest wound size (30 x 5 mm) 
(Capek et al., 2012). The size of this wound is much larger than the average periodontal pocket 
defect. Thus, it was concluded that Gore
®
 BIO-A
®
 could withstand the force needed for suturing 
into place whether hydrated in PBS or media. Overall, the team concluded that media has no 
significant effect on the mechanical properties of Gore
®
 BIO-A
®
 and it can withstand the force 
needed to suture the graft into place if used in a clinical setting.  
7.4 Designing for Overreaching Effects 
7.4.1 Designing for Political Ramifications 
Throughout the development of this alternative graft for the treatment of periodontitis, 
the project team had to take into consideration the overreaching impact that this design could 
have, not only in terms of the project goal and the results obtained through testing, but the global 
ramifications that the product could lead to upon production and release into the market. The use 
of the alternative graft as opposed to the autologous graft has the potential to decrease the 
surgical component of the current gold standard procedure. This shift in methodology for treating 
periodontitis could influence policies dictating dental practice by furthering the shift that has 
occurred between dentists and periodontists. Periodontal care used to be clearly divided between 
the general dentists and the periodontists. The general dentists would take steps to prevent the 
disease but once the preventative measures failed, they would then refer patients to the 
periodontist for treatment (Flemmig and Beikler, 2013). Recently, there has been a shift in that 
divide with general dentists treating cases of mild to moderate periodontitis more often, only 
referring patients to periodontists when they suffer from severe periodontitis that has already led 
to tooth loss (Flemmig and Beikler, 2013). This shift can be seen in guidelines recently 
developed by the American Academy of Periodontology which have denoted patients that must 
be referred to a periodontist as “Level 3” patients and characterizes them as patients with severe, 
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chronic, and aggressive forms of periodontitis that may involve bony defects and a high amount 
of gingival recession (Krebs and Clem, 2006). As can be seen in this description, patients with 
milder forms of the disease do not fall under this category and may therefore be treated by a 
general dentist or by a cooperative method between a general dentist and periodontist team 
(Krebs and Clem, 2006). The decreased amount of surgery that would be necessary to treat 
periodontitis if the alternative graft replaces the autologous graft could lead to a greater number 
of periodontal cases being treated by general dentists. Due to this, there would need to be a shift 
in policy that addresses the increase in general dentists being involved in the treatment of the 
disease. This shift in policy could then affect the curriculum utilized in dental schools since 
general dentists would have to have a greater knowledge of the treatment of periodontitis. The 
shift could also affect insurance policies for both the practitioner and the patient. The general 
dentists would have added responsibilities in regards to periodontal treatment which could lead 
to an increase in dental malpractice insurance. On the other hand, the insurance co-pay may 
decrease for patients since there would be a greater number of unspecialized practitioners able to 
treat them without the need for a referral. 
7.4.2 Designing for Economics 
This shift in responsibility would not only affect political regulations but also the 
economics of the dental market. In many fields specialized professionals often have a greater 
income than general practitioners. This has been proven to hold true when comparing 
periodontists to general dentists. The American Dental Association’s Survey of Dental Practice 
from 1997 showed that, on average, periodontists had a net income of $165,640 which was found 
to be higher than the average general dentist’s salary by 24.1% (Brown, Johns, and Wall, 2002). 
This discrepancy between the salaries may be expected to decrease as general dentists take on 
more periodontal cases due to the elimination of the second surgery that would be provided by 
the use of the team’s alternative graft.  
7.4.3 Designing for Societal Influence  
The sale of the alternative graft designed throughout this project is expected to influence 
the economic breakdown of the dental market but it can also influence society, particularly 
through the marketing that would be used to increase sales. The marketing for the alternative 
graft would benefit from explaining to people what periodontitis is and just how prevalent it is as 
well as why it is a good alternative to traditional flap surgery. It has been found that almost half 
of American adults over the age of 30 suffer from periodontitis which arises from a bacterial 
infection of the gums (Eke et al., 2012). This is a fact that many people are not aware of now but 
could learn through the advertisement for the synthetic graft. Emphasizing these kinds of facts 
about the disease can lead to increased awareness of dental health. The use of images of the 
mouths of people with severe periodontitis in advertising can prove to be a strong tool which can 
cause people to be more mindful of their dental visits in order to avoid periodontitis. 
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7.4.4 Designing for Health and Safety 
 Advertisements for the alternative graft would also benefit from discussing the 
improvements to patient health that the graft would have over the current gold standard: flap 
surgery. The alternative graft would present the ability to regenerate the lost gingival tissue 
without the use of an autologous graft as well as dictate the variables that could optimize the 
regeneration of the tissue (Chen and Jin, 2010).  Using the synthetic graft would eliminate the 
surgery required to harvest donor tissue from the roof of the patient’s mouth. The elimination of 
this second surgery would decrease the pain felt by the patient as well as the risk of infection 
which could lead to an overall better recovery. Patients with very severe periodontitis that 
involves a high degree of gum recession would have a better chance of receiving treatment since 
the synthetic graft would address the current graft material limitation presented by using tissue 
from the roof of the mouth. 
7.4.5 Designing for Ethical Concerns 
 Before the synthetic graft can make its way to use as part of periodontal treatment, it 
must first become approved by the Food and Drug Administration (FDA), which requires a lot of 
validation and testing. Though this project addressed some of the preliminary in vitro testing, 
more would have to be done in order to evaluate each part that makes up the graft. The cellular 
component would have to be tested for sterility, purity, viability, identity, biologic activity, in 
this case the ability to deposit type I collagen, and stability over time (Lee, 2010). The 
scaffolding that would act as the delivery system of the cells into the infected area would also 
have to be tested in various areas. It would have to be tested in order to determine if it is in fact 
necessary for the purpose of the graft. The scaffold would be tested for biocompatibility, 
physical and mechanical properties, as well as how it degrades, if anything is produced when it 
degrades, and how cells attach and grow within the scaffold as well as how sterile it is before the 
addition of cells and how it is kept sterile through aseptic technique once the cells have been 
seeded onto it (Lee, 2010). The graft would then have to move on to in vivo testing in animal 
models before use in human clinical trials. The animal model is used in order to test any 
cytotoxic effects that the scaffold may have on a living system as well as provide proof of its 
ability to achieve gum tissue regeneration (Lee et al., 2009). Rodents are usually the first stage in 
animal model testing for dental applications for the testing of safety while canines are the 
preferred model for testing the efficacy of dental therapies (Pelligrin et al., 2009). It is 
unfortunate that animals must be used for this purpose and it is a topic for great ethical debate 
but the use of the animal model is important in assessing the efficacy and safety of the proposed 
alternative graft. 
7.4.6 Designing for Manufacturability 
 The use of animal testing is important since it validates that the alternative material the 
team proposes was designed and produced in a way that allowed it to work efficiently while also 
being safe to use. The method used to make the alternative graft that was tested would be very 
reproducible due to the use of Gore
®
 Bio-A
®
 as the scaffolding material. Gore
®
 Bio-A
®
 is 
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already approved by the FDA for clinical use and already has a manufacturing protocol set in 
place since it is a material currently available on the market (Gore
®
 Bio-A
®
 Tissue 
Reinforcement, 2012). The oral connective tissue fibroblasts utilized by the team in the design of 
the alternative graft have a standard culture and seeding protocol that could be followed simply 
in order to recreate the graft. The most difficult part of the process from a manufacturing 
standpoint would be cell sourcing and creating a cell bank large enough to be able to mass 
produce the graft. This manufacturing protocol could be developed through a literature search 
into methods currently being used by companies such as Olympus Biotech and Organogenesis 
Inc. that depend on biologic products derived from cells for some of their products.  
7.4.7 Designing for Environmental Impact and Sustainability 
 When determining the methods that can be used to manufacture the graft in larger 
quantities, one must keep the environmental impact that this would have and the ability to use 
sustainable methods in mind. Building an area where the graft can be produced could lead to 
many of the drawbacks connected to industrialization such as clearing of trees that provide clean 
air, upsetting the fauna and flora of the chosen space, and adding to the carbon footprint 
unnaturally affecting climate change. These negative environmental impacts can be combatted 
by actively using sustainable methods to power the production of the graft. The grafts can be 
manufactured using renewable energy such as wind turbines or solar panels depending on where 
the site is located. “Green” appliances could be used to decrease the amount of electricity needed 
to run manufacturing such as using high efficiency light bulbs to brighten the work area.  
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Chapter 8: Conclusion and Recommendations 
 Periodontitis is a serious disease that affects a large number of people from a variety of 
age groups and demographics. The infection progresses from gingivitis to a full receding of the 
gums which leads to tooth mobility and often tooth loss. The current gold standard for treating 
periodontitis is palatal surgery where a graft is obtained from tissue taken from the roof of the 
mouth. The palatal graft is then sutured into the infected area. Although it is the gold standard, 
palatal graft surgery has drawbacks that have led to the need for an alternative. Patients who 
undergo palatal surgery suffer from increased pain and have a higher risk of infection due to the 
two wound sites, one at the infected site and another at the roof of the mouth. There is also a 
limit to the amount of tissue available at the donor site and often there is not enough to treat the 
entire infection site. In order to address these drawbacks, many dental professionals have turned 
to AlloDerm
®
 which is an acellular dermal matrix derived from cadaver skin. Although 
AlloDerm
®
 addresses the donor site limitation, it is a difficult material for periodontists to work 
with, often tearing and folding improperly when being prepared to fit and be sutured into the 
wound site.  
In order to address the shortcomings of the current treatment methods, the team proposed 
to create an alternative graft material that mimics the mechanical and cellular properties of the 
mouth. Through the use of a design process and an extensive literature review, the project team 
chose to seed a synthetic scaffold that has already been approved by the FDA, Gore
®
 BIO-A
®
, 
with fibroblasts derived from oral connective tissue. The team hypothesized that oral connective 
tissue fibroblasts would contribute to the deposition of gingival tissue-specific extracellular 
matrix suitable for oral surgical application. 
  This design was chosen because it seemed to be able to meet the objectives developed 
through the design process as well as prove or disprove the hypothesis. The objectives for the 
scaffold were that it must promote collagen deposition, allow cell infiltration and increased cell 
count, and demonstrate mechanical stability. The promotion of collagen is essential since it is the 
major component of the extracellular matrix of gum tissue and therefore necessary for the 
scaffold to mimic the cellular properties of gingival tissue. The team hypothesized that this could 
be achieved through the use of oral connective tissue fibroblasts since they are the dominant cell 
type of the tissue lost to periodontitis. The promotion of collagen was tested histologically 
through the use of a picrosirius red/fast green stain. The results showed that there was in fact an 
increase in collagen produced over time but the overall production of collagen was very minimal. 
Cell infiltration and increased cell adherence were tested through a Hoechst stain and a Harris 
hematoxylin and eosin stain. Both tests showed a qualitatively determined increase in the amount 
of cells on the scaffold and an increase in distribution of the cells over time though the cells were 
unable to uniformly distribute themselves throughout the entire scaffold. The increase in cell 
amount means that there are more cells that can deposit collagen onto the scaffold and their even 
distribution is essential for uniform tissue regeneration. The graft developed by the project team 
had to demonstrate mechanical stability that would allow a periodontist to handle it without 
folding or tearing and suture it into place. This was tested through the use of uniaxial tensile 
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testing and suture pullout testing. The results showed that Gore
®
 BIO-A
®
 had a higher elastic 
modulus meaning that it could elastically deform under larger forces than AlloDerm
®
 without 
tearing. The suture pullout testing also showed that the material could be held in place with 
sutures.  
 Although the objectives were met, the results gathered are not strong enough to support 
conclusive success of the graft. The project team believes that the graft could be feasible if it 
were to be improved. The team recommends the use of further time points that would allow the 
scaffold to culture with the cells for a longer period of time. The collagen formation shown in the 
data presented in Chapter 6 proves that the oral connective tissue fibroblasts could contribute to 
the deposition of gingival tissue-specific extracellular matrix but it did not occur in an amount 
large enough to mimic gingival tissue as closely as the team believes could have occurred had 
the cells been given more time to deposit collagen. The team also believes that the graft could be 
improved by allowing more time for the cells to create a layer of collagen and then removing the 
cells. This would allow the cells to be sourced from a bank without concern of rejection due to 
an immune response.    
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Appendix B: Objectives Tree 
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Appendix C: Pairwise Comparison Chart 
 
 Promote 
collagen 
deposition 
Allow cell 
infiltration 
and cell 
adherence 
Demonstrate 
mechanical 
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Total 
Promote 
collagen 
deposition 
-------- 1 1 2 
Allow cell 
infiltration 
and cell 
adherence 
0 -------- 1 1 
Deomonstrate 
mechanical 
stability 
0 0 -------- 0 
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Appendix D: Interview with Dr. Lee 
 
Dr. Angie Lee, DMD 
Telephone number: (508) 363-4400 
Interviewed at 
65 Elm Street 
Worcester, MA 01609 
Date: 10/02/2012  
 
1. How does a person qualify for flap surgery? How advanced does the disease have to 
be? 
Flap surgery is a very general term, but the surgery you are talking about varies. It really 
depends on the patient. Sometimes the gums may not need to be regenerated.  
 
2. Can you please describe how traditional flap surgery is performed? Have you ever 
had to perform the surgery using artificial tissue? 
The first thing is we numb the patient then we push away the gums at the recipient site. 
We then collect the graft from the roof of the mouth and resize it to fit the recipient site. 
The donor site is then sutured and the graft is sutured into place at the recipient site. I 
have no preference to using the roof of the mouth or artificial tissue. The patient has the 
ultimate choice.  
 
3. Do you have a preference of using roof of the mouth donor or artificial donor? 
Why? 
I have no preference for using either. However, the allograft is recommended for larger 
areas to be grafted because there is limited tissue from the roof of the mouth.  
 
4. Is there any preparation that needs to be done before the procedure takes place, 
either with the roof of the mouth donor or artificial tissue? 
Before the surgery takes place the recipient site is thoroughly cleaned to get rid of the 
bacteria causing the disease. If using artificial tissue it has to be soaked in saline to 
reconstitute it before use.  
 
5. About how long does flap surgery take? 
Flap surgery takes about an hour.  
 
6. About how long does it take for the donor site (if applicable) and recipient site take 
to heal? 
It takes around 2-3 months for the mouth to heal histologically, but by the end of the first 
week the patient has no more discomfort.  
 
7. Do the patients have any restrictions on what they can or cannot eat for  a time 
period after the surgery? How long? 
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The recipient site is critical and should not be touched for about a week. Patients 
shouldn’t be eating sharp or hard food that could cause mechanical movement and 
compromise the outcome. But with that said I do not give my patients any restrictions on 
what they should eat. I tell them to use their better judgment when choosing their foods.  
 
8. How does a person take care of their mouth after surgery? 
Patients are not supposed to brush for a week because it might disturb the recipient site. 
Instead they use an antibacterial mouthwash called Peridex. Patients also take ibuprofen 
(600 mg) for 3 day as an anti-inflammatory.  
 
9. Are there complications when you use artificial tissue? 
The graft works well; in fact we get better tissue color with artificial tissue than the graft 
from the roof of the mouth.  
 
10. How much does this surgery cost? 
The cost depends on the tooth/size of the grafting, but it is the same cost for using roof of 
the mouth and allograft.  
 
11. What would you change about the surgery procedure to make it better? Easier to 
work with? 
The graft words well, but maybe something that would make it better would be if it could 
accelerate healing. Maybe incorporate stem cells?  
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Appendix E: Cell Culture Protocols 
 
To make 100 mL of complete medium:    
 Ingredients (all at room temp): 
o 44.5 mL of DMEM-L-Glutamine 
o 44.5 mL of F12 
o 10 mL of 10% FBS 
o 1 mL penn/strep 
 Add 44.5 mL of DMEM-L-Glutamine, 44.5 mL of F12, 10 mL FBS, and 1 mL of 
penn/strep into an empty 100 mL bottle 
 
Sub-Culturing Cells Protocol: 
1. Wash down entire hood with 70% Isopropyl alcohol 
2. Take cells out of incubator  
3. Wash cells with 5 mL of PBS (amount of growth medium the cells were in) 
 Swirl around dish 
4. Aspirate all liquid off the cells 
5. Add 1 mL of 0.05% trypsin (you can use 1 mL for a 10 cm dish) 
 Swirl around dish 
6. Incubate at 37°C for about 3-5 minutes 
7. Observe detachment under microscope after incubation 
8. Place dish back in hood 
9. Add 4 mL of complete medium to dish 
10. Wash cells off surface of dish by pipetting 2-3 times over surface of the dish 
11. Pipet entire contents of dish to 15 mL centrifuge tube 
12. Centrifuge the 5 mL in the centrifuge tube at 1000 RPM for 5 minutes, balancing the tube 
with equal amount in the opposite position 
13. After 5 minutes are up, take out tube and observe cell pellet at bottom of tube 
14. Aspirate off supernatant, leaving the cell pellet intact 
15. Resuspend cells by adding x amount of mL of complete medium to cell pellet (will vary 
depending on the split) 
16. Pipet up and down 2-3 times to mix, keeping only the tip of the pipet in the liquid at all 
times, forcefully enough to mix the cells but not too forceful that bubbles form 
17. Add desired amount of mL of cell suspension to each dish 
18. Add enough complete medium to each dish so that there is a total of 10 mL of liquid in 
each dish 
19. Gently swirl dishes to spread uniformly 
20. Incubate dishes at 37°C overnight, observe next day for attachment and confluency 
21. Cap all bottles and wash down entire hood, disposing of trash in appropriate waste 
containers 
 
Counting Cells Protocol: 
1. Follow steps 1-11 of the Sub-Culturing Cells Protocol 
2. Once the entire contents of each dish are pipetted into a centrifuge tube, transfer a small 
aliquot of cell suspension (50 μL is fine) to an eppendorf tube 
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3. Using a 10 μL pipette, remove 10 μL from the eppendorf tube 
4. The 10 μL is then loaded into the chamber of a hemocytometer 
5. The hemocytometer is then viewed under a microscope so that the etched on grid can be 
clearly seen 
6. The number of cells are then counted – only counting the number of cells that are present 
in the four corner squares 
 Cells that fall on the top and left edge lines are omitted from the cell count in 
order to provide for the most accurate cell count 
7. The number of cells/mL and total number of cells in the cell suspension are then able to 
be calculated using the following calculations: 
 (# of cells counted/# of squares counted) x 104 x dilution factor = # of 
cells/mL 
 # of cells/mL x mL of cell suspension = total # of cells in cell suspension 
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Appendix F: Processing and Embedding Protocols 
 
Processing: 
1. Place sample in cassette, label with pencil or histoquill with sample description and date 
2. Soak in 10% neutral buffered formalin for 30 minutes 
3. Soak in 70% ethanol for 15 minutes 
4. Soak in 80% ethanol for 15 minutes 
5. Soak in 95% ethanol for 20 minutes 
6. Soak in 95% ethanol for 25 minutes 
7. Soak in 100% ethanol for 25 minutes 
8. Soak in 100% ethanol for 25 minutes 
9. Soak in 100% ethanol for 25 minutes 
10. Soak in xylene (8) for 30 minutes 
11. Soak in xylene (9) for 30 minutes 
12. Place in paraffin (10) for 30 minutes 
13. Place in paraffin (11) for 30 minutes 
 
Embedding: 
Embed processed sample using Leica Embedding Station EG1160 
1. Pour wax in appropriately sized mold 
2. Place sample in mold in correct orientation 
3. Pour more wax into mold, over sample 
4. Place cassette base on top of the mold 
5. Pour additional wax over the cassette base in order to ensure that the finished sample 
block will be attached to the cassette base 
6. Place the mold onto the cold plate set at -05˚C for 30 minutes 
7. Remove the finished sample block from the mold 
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Appendix G: First Hematoxylin and Eosin Protocol 
 
1. De-paraffinize slides in xylene (1) for 3 minutes 
2. De-paraffinize slides in xylene (2) for 3 minutes 
3. De-paraffinize slides in xylene (3) for 3 minutes 
4. Hydrate slides in 100% ethanol for 3 minutes 
5. Hydrate slides in 100% ethanol for 3 minutes 
6. Hydrate slides in 95% ethanol for 1 minute 
7. Hydrate slides in 70% ethanol for 1 minute 
8. Rinse in running water until clear 
9. Stain with Harris hematoxylin for 5 minutes 
10. Rinse in running water until clear 
11. Differentiate sections in 1% HCL mixed with 70% ethanol (0.25 ml HCl to 100 ml 70% 
ethanol) for 2-3 quick dips 
12. Rinse in running water for 30 seconds 
13. Counterstain with eosin-y for 1 minute 
14. Dehydrate slides in 95% ethanol for 30 seconds 
15. Dehydrate slides in 95% ethanol for 30 seconds 
16. Dehydrate slides in 100% ethanol for 1 minute 
17. Dehydrate slides in 100% ethanol for 1 minute 
18. Clear in xylene (4) for 1 minute 
19. Clear in xylene (4) for 1 minute 
20. Clear in xylene (4) for 1 minute 
21. Coverslip slides using synthetic mounting medium 
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Appendix H: Final Hematoxylin and Eosin Protocol 
 
This protocol was developed by Hans Snyder, B.S. (HT), Histology Core Manager, Life Sciences 
and Bioengineering Center, Worcester Polytechnic Institute.  
 
1. De-paraffinize slides in xylene (1) for 2 minutes 
2. De-paraffinize slides in xylene (2) for 2 minutes 
3. Clear slides in 100% ethanol for 2 minutes 
4. Clear slides in 100% ethanol for 2 minutes 
5. Hydrate slides in 95% ethanol for 2 minutes 
6. Hydrate slides in running water for 5 minutes 
7. Stain slides with Harris hematoxylin for 10 minutes 
8. Rinse slides in running water for 2 minutes 
9. Differentiate in acid alcohol for 1 quick dip 
10. Rinse in water for 3 quick dips 
11. Dip in ammonia water for 15 seconds 
12. Wash in running water for 10 minutes 
13. Place in 95% ethanol for 2 minutes 
14. Counterstain with eosin-y for 1 minute 
15. Dehydrate in 95% ethanol for 1 minute 
16. Dehydrate in 100% ethanol for 1 minute 
17. Dehydrate in 100% ethanol for 2 minutes 
18. Dehydrate in 100% ethanol for 2 minutes 
19. Clear in xylene (3) for 2 minutes 
20. Clear in xylene (4) for 5 minutes 
21. Coverslip slides with mounting media 
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Appendix I: Final Picrosirius Red/Green Protocol 
 
This protocol was developed by Hans Snyder, B.S. (HT), Histology Core Manager, Life Sciences 
and Bioengineering Center, Worcester Polytechnic Institute.  
 
1. De-paraffinize slides in xylene (1) for 2 minutes 
2. De-paraffinize slides in xylene (2) for 2 minutes 
3. Clear slides in 100% ethanol for 2 minutes 
4. Clear slides in 100% ethanol for 2 minutes 
5. Hydrate slides in 95% ethanol for 2 minutes 
6. Hydrate slides in running water for 5 minutes 
7. Stain slides with Harris hematoxylin for 10 minutes 
8. Rinse slides in running water for 2 minutes 
9. Stain with Picro fast green for 30 minutes 
10. Rinse- fill container and dump once 
11. Stain with Picrosirius red for 30 minutes 
12. Rinse- fill container and dump once 
13. Dehydrate in 95% ethanol for 30 seconds 
14. Dehydrate in 100% ethanol for 1 minute 
15. Dehydrate in 100% ethanol for 2 minutes 
16. Dehydrate in 100% ethanol for 2 minutes 
17. Clear in xylene (3) for 2 minutes 
18. Clear in xylene (4) or 5 minutes 
19. Coverslip slides with mounting media 
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Appendix J: Cycles Used on the Automated Processor 
The following cycles were run on the ATP™ (Automated Tissue Processor) from Triangle 
Biomedical Sciences, Durham, NC. 
 
Long No Fix Cycle: 
1. 70% ethanol for 1 hour 
2. 80% ethanol for 1 hour 
3. 95% ethanol for 1 hour 
4. 95% ethanol for 1 hour 
5. 100% ethanol for 1 hour 
6. 100% ethanol for 1.5 hours 
7. Xylene for 30 minutes 
8. Xylene for 1 hour 
9. Wax 11 for 1 hour 
10. Wax 12 for 1 hour 
11. Wax 11 for 1 hour 
12. Wax 12 for 1 hour 
 
Short No Fix Cycle: 
1. 70% ethanol for 20 minutes 
2. 80% ethanol for 20 minutes 
3. 95% ethanol for 20 minutes 
4. 95% ethanol for 20 minutes 
5. 100% ethanol for 20 minutes 
6. 100% ethanol for 30 minutes 
7. Xylene for 20 minutes 
8. Xylene for 20 minutes 
9. Wax 11 for 30 minutes 
10. Wax 12 for 30 minutes 
11. Wax 12 for 30 minutes 
12. Wax 12 for 30 minutes 
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Appendix K: Mechanical Testing Protocols 
 
Uniaxial Tensile Testing: 
1. Prepare 6 rectangular shaped samples with the following dimensions: 
a. Length: 2 cm 
b. Width: 0.5 cm 
2. Hydrate 3 samples in PBS for 48 hours and 3 samples in media for 48 hours 
3. Set up the Instron machine using the 2kN load cell and the screw action grips.  
4. Plug in the load cell into the back of the machine. 
5. Restart computer 
6. Turn on Instron machine 
7. Start up Bluehill Software and the console  
a. Bluehill Software collects the data 
b. The Console sets the limits of the machine and calibrates the load 
8. In Bluehill write the following program: 
a. Set key 1 to: Reset Gauge Length 
b. Set key 2 to: Balance Load 
c. Set the rate to 10 mm/min 
d. Set the parameters of the sample: 
i. Width: 0.5 cm  
ii. Thickness:1.7 mm 
e. Set the program to prompt you about the length before beginning test 
9. On the console: 
a. Set the limits 
i. Set the upper limit to 1190 N 
ii. Set the lower limit to -1190 N 
iii. Make sure the Actuator is set to OFF 
b. Calibrate the load 
10. Place sample between the grips 
11. Measure the length of the material between the grips using a ruler and write it in the 
prompt section before beginning the test 
12. Preload the sample manually to 1 N 
13. Zero the Reset Gauge Length by clicking on key 1 
14. Click Start 
15. The machine will apply a load at the rate of 10 mm/min and when the material breaks in 
half it will automatically stop 
16. Click the Return button on the Bluehill software to return the screw action grips to their 
original position.  
17. Repeat steps 9-15 for as many trials as needed.  
18. When complete click the Finish button on the Bluehill software to save the data collected.  
 
Suture Pullout Protocol: 
1. Prepare 6 rectangular shaped samples with the following dimensions: 
a. Length: 2 cm 
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b. Width: 0.5 cm 
2. Hydrate 3 samples in PBS for 48 hours and 3 samples in media for 48 hours 
3. Using the 3-0 silk sutures with an attached needle, pierce the sample 5 mm from the short 
edge of the sample and double knot the loop. Make sure the loop is big enough to fit over 
the suture grip. 
4. Set up the Instron machine using the 2kN load cell and one screw action grip and the 
suture grip.   
5. Plug in the load cell into the back of the machine. 
6. Restart computer 
7. Turn on Instron machine 
8. Start up Bluehill Software and the console  
a. Bluehill Software collects the data 
b. The Console sets the limits of the machine and calibrates the load 
9. In Bluehill write the following program: 
a. Set key 1 to: Reset Gauge Length 
b. Set key 2 to: Balance Load 
c. Set the rate to 60mm/sec 
d. Set the parameters of the sample: 
i. Width: 0.5 cm  
ii. Thickness:1.7 mm 
e. Set the program to prompt you about the length before beginning test 
10. On the console: 
a. Set the limits 
i. Set the upper limit to 1190 N 
ii. Set the lower limit to -1190 N 
iii. Make sure the Actuator is set to OFF 
b. Calibrate the load 
11. Place sample between the screw action grip and the suture grip 
12. Measure the length of the material between the grips using a ruler and write it in the 
prompt section before beginning the test 
13. Preload the sample manually to make the sample taut between the grips and the suture 
grip. 
14. Zero the Reset Gauge Length by clicking on key 1 
15. Click Start 
16. The machine will apply a load at the rate of 60 mm/sec and when the suture breaks free 
from the material the machine will automatically stop 
17. Click the Return button on the Bluehill software to return the screw action grips to their 
original position.  
18. Repeat steps 11-17 for as many trials as needed.  
19. When complete click the Finish button on the Bluehill software to save the data collected.  
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Appendix L: Developing Histology 
 
As stated previously, Gore
®
 BIO-A
®
 is a porous, fibrous synthetic material made up of 
67% poly-glycolic acid and 33% trimethylene carbonate. As such, the material’s characteristics 
presented difficulties for the in vitro histological testing required to validate that a few of the 
project team’s objectives were met. In order to determine the most efficient methodology for the 
testing of  Gore
®
 BIO-A
®
 the team developed a series of trials to test different methods of 
staining the material samples.  
The first trial was run using Gore
®
 BIO-A
®
 that had been seeded with gingival fibroblasts 
and cultured for 2 days. The sample was hand processed and then embedded using the protocol 
outlined in Appendix F. This process can also be visualized in Figure 19 and Figure 20. The 
embedded Gore
®
 BIO-A
®
 was then cut into paraffinized sections. The sections were cut by using 
a microtome. The sample was faced, removing excess wax from the embedded block until the 
blade began sectioning the desired material. Once faced, the embedded block was placed into ice 
water for about 20 minutes. After being dried and placed onto the microtome, the sample was cut 
into a ribbon of adjoined 6 μm thick sections. The ribbon was placed onto a water bath set at 
42˚C. Using blunt forceps, the ribbon was separated into groups of 2-3 sections. Holding a slide 
in the water bath and using the very tip of a paint brush to guide the sections, the samples were 
placed onto each slide. The slides were then baked at 60˚C for 30 minutes.  
 
 
Figure 19: Series of alcohols used to dehydrate the samples during the hand processing protocol outlined in Appendix F 
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Figure 20: Xylenes used during hand processing outlined in Appendix F 
 The prepared slides were then used to test a nuclear stain, hematoxylin and eosin, and a 
stain for marking collagen produced, picrosirius red/green. The protocol for the hematoxylin and 
eosin stain used can be seen in Appendix G and the picrosirius red/green staining protocol can be 
found in Appendix I. The staining set up can also be seen in Figure 21 and Figure 22. Due to the 
material properties, the samples fell off the slides and therefore could not be imaged or used to 
obtain data. The project team repeated the methodology of trial 1, from processing to staining, 
for trial 2 in order to ensure that the loss of sample was due to methodology and not to human 
error. The samples fell off the slides again and therefore could not be imaged or used to obtain 
data.  
 
 
Figure 21: Histology set-up used for vertical staining during hematoxylin and eosin protocol and picrosirius red/green 
protocol 
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Figure 22: Leica Embedding Station EG1160 that was used to embed all samples 
 For trial 3, the team processed and embedded another sample of Gore
®
 BIO-A
®
, which 
had been cultured with gingival fibroblasts for 6 days, using the same methods as the previous 2 
trials. Instead of using neutral slides the project team opted to use positively charged glass slides 
in order to determine if this change in polarity would allow the slides to retain the sample 
throughout the staining process. The slides were again stained with hematoxylin and eosin as 
well as picrosirius red/green. The results obtained matched trials 1 and 2 in the loss of sample 
and inability to obtain an image. 
 In order to carry out trial 4, the project team reverted back to neutral slides and instead 
changed the staining protocol in order to stain slides of the Gore
®
 BIO-A
®
 embedded for trial 3. 
The slides were stained using adaptations of the protocols found in Appendix G and Appendix I. 
The hematoxylin and eosin stain was performed as dictated in the protocol with the replacement 
of the usual Harris hematoxylin stain with a hematoxylin and water solution made to a 1:1 ratio. 
The same solution ratio was used during the picrosirius red/green stain for the picrosirius red and 
fast green dyes as well. This was done in order to decrease the acidity of the dyes so that there 
was less probability that acid erosion would cause the samples to fall away from the slides. A 
human skin control was run for the picrosirius red/green stain to ensure that the team was indeed 
using the correct staining technique. The human skin control stained positive for collagen, as 
would be expected, showing that the stain was done correctly. The sample slides provided 
different results during this trial. Gore
®
 BIO-A
®
 still could not be found, indicating that it had 
fallen off the slides, but the stained cells could be viewed and imaged using brightfield 
microscopy. Although the cells could be viewed, the project team determined that a method that 
would allow both the cells and the material to stay on the slides would be ideal since the location 
of the cells on the scaffold is important, for the purpose of the objectives, and cannot be 
determined if the sample cannot be seen.  
 
 78 
 
 
Figure 23: Human skin control stained with picrosirius red/green that had been diluted to 1:1 solution with water imaged 
using brightfield at 200X 
 
 
Figure 24: Gingival fibroblasts after being seeded and cultured on Gore® BIO-A® for 6 days, stained with diluted (1:1 
ratio with water) Harris hematoxylin and eosin and viewed using brightfield at 200X 
 
Figure 25: Gingival fibroblasts after being seeded and cultured on Gore® BIO-A® for 6 days, stained with diluted (1:1 
ratio with water) picrosirius red/green and viewed using brightfield at 200X 
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 Trial 5 began with the processing and embedding of a Gore
®
 BIO-A
®
 sample that had 
been coated in type I collagen and then seeded with cells and cultured for 5 days. The sections 
were prepared on slides that had been coated in either white glue or wood glue. The team 
predicted that the adhesives would aid in retaining the sample on the slide. The staining was also 
done in the usual vertical orientation as well as on slides that had been placed horizontally in the 
hopes that this would decrease the chances of losing the material. The slides were stained 
following the hematoxylin and eosin protocol found in Appendix H and the picrosirus red/green 
protocol found in Appendix I. After staining, it was clear that the sample had once again been 
lost during staining from the slides that were stained vertically and the horizontally stained wood 
glue slides. The slides that had been coated in white glue and horizontally stained appeared to 
have retained the samples. When viewed under phase contrast the team was able to identify the 
location of the scaffold but not the location of the cells. The team believes that the white glue 
coating impeded the proper staining of the cells and, although it retained the material, would not 
yield the proper data recorded to support design validation. 
 
 
Figure 26: Histology setup used for vertical staining currently being used to stain slides with picrosirius red dye 
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Figure 27: Gore® Bio-A® scaffolding coated in type I collagen and then seeded and cultured with gingival fibroblasts for 5 
days, sectioned onto slide coated with white glue, and stained with hematoxylin and eosin, viewed using phase contrast at 
40X 
 The next trial, trial 6, was run using Gore
®
 BIO-A
®
 that had not been previously seeded 
with cells or given any kind of coating. The project team placed the material into a mold and 
covered it in agarose so that the agarose could preserve the structural integrity of the samples 
during staining. The mold was then placed on a cold plate set at -05˚ for about 5 minutes, until 
the opaqueness of the agarose indicated that it was solid. The sample in agarose was placed into 
a cassette and placed in the ATP™ (Automated Tissue Processor) from Triangle Biomedical 
Sciences, Durham, NC. The processor was set to run the long no fix cycle overnight. After 
processing, the sample was embedded and cut onto slides that were either neutral, positively 
charged, or had been coated with either white glue or ploy-L-lysine. One of each type of slide 
was then stained in the following groups: 
 Vertically stained picrosirius red/green slides 
 Horizontally stained picrosirius red/green slides 
 Vertically stained hematoxylin and eosin 
 Horizontally stained hematoxylin and eosin 
The vertically stained slides all lost either all of the sample or had only isolated areas where the 
material was retained. The same held true for all of the horizontally stained slides except for 
those coated in poly-L-lysine.  
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Figure 28: Gore® BIO-A® scaffolding that had  been embedded in agarose before being processed and embedded in 
paraffin, sectioned onto a poly-L-lysine coated slide and stained with hematoxylin and eosin and viewed at 40X using 
phase contrast 
 The team ran trial 7 in order to ensure that the combination of agarose and poly-L-lysine 
was in fact responsible for keeping the section intact and on the slide. The team cut slides of the 
material in agarose onto poly-L-lysine slides as well as the material coated in type I collagen that 
had previously been embedded, also on poly-L-lysine slides. The slides were stained horizontally 
with both hematoxylin and eosin, and picrosirius red/green. The results demonstrated that the use 
of poly-L-lysine coating on the slides was not sufficient for producing the same caliber of 
histological results as the combination of the coating and the agarose embedding. This trial led 
the team to decide on embedding the material in agarose prior to processing in order to obtain 
better histological data.  
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Appendix M: Functions/Means Chart 
 
 
 
 
 
 
 
 
 
